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ABSTRACT 
Among the general US population, cardiovascular disease (CVD) 
is the main cause of mortality for Mexican-Americans. CVD is 
less prevalent among Mexican-Americans than non-Hispanic 
Whites or African Americans.  However, there is limited research 
regarding the factors associated with increased CVD risk among 
Mexican-Americans.  Thus, this cross-sectional study was 
conducted to evaluate the effects of non-biological factors 
(income, education, employment, acculturation) and diet on CVD 
risk factors in 75 Mexican-American adults (26 males, 49 
females; age=37.6±9.3 y, BMI=28.9±5.3 kg/m2, systolic 
BP=117±11 mmHg, diastolic BP=73±9 mmHg, LDL 
cholesterol=114±32 mg/dL, HDL cholesterol=44±11 mg/dL, 
triglycerides=115±61 mg/dL, serum glucose=92±7 mg/dL).  
Aside from collecting anthropometric measurements, blood 
pressure, and measuring fasting blood lipids, glucose, and 
insulin, information about participants’ socioeconomic status, 
income, employment, education, and acculturation were 
gathered using a survey.  Diet data was collected using the 
Southwestern Food Frequency Questionnaire.  Weight, BMI, and 
waist circumference were significantly greater for those with a 
monthly income of <$3000 than for those earning >$3000 
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(81±15 kg vs. 71±15 kg; 29.8±4.6 kg/m2 vs. 26.5±5.1 kg/m2; 
98±12 cm vs. 89±14 cm; respectively) and with an education 
level of high school graduate or less than for those with some 
college (84±16 kg vs. 72±14 kg; 30.6±4.2 kg/m2 vs. 26.9±4.9 
kg/m2; 100±11 cm vs. 91±13 cm; respectively).  HDL-C was 
higher for those with a monthly income of >$3000 than those 
earning <$3000 (49±12 mg/dL vs. 41±10 mg/dL), those with 
some college education than those with high school or less 
(47±10 mg/dL vs. 37±9 mg/dL), and for those employed than 
those not employed (46±10 mg/dL vs. 40±12 mg/dL).  There 
was no association between acculturation and CVD risk factors.  
Percent of energy consumed from fat was greater and percent of 
energy from carbohydrates was lower in those earning <$3000 
monthly than those earning >$3000 (32±5% vs. 29±3%; 
52±8% vs. 56±4%; respectively).  Greater acculturation to the 
Anglo culture was negatively correlated with body fat percentage 
(r=-0.238, p=0.043) and serum glucose (r=-0.265, p=0.024).  
Overall, these results suggest that factors related to sociocultural 
and socioeconomic status may affect cardiometabolic disease 
risk in Mexican-Americans living in the Phoenix metropolitan 
area. 
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INTRODUCTION 
Cardiovascular disease (CVD) is the leading cause of death 
among Americans [1].  In 2005, CVD-related deaths accounted 
for 35% of all deaths in the United States [2].  According to the 
Centers for Disease Control and Prevention, over 28,000 
Mexican-Americans have CVD, which is higher than any other 
cause of death in this ethnic group [1]. Despite the fact that this 
group does not have a higher prevalence of CVD than White 
Americans or African Americans, it is still the number 1 cause of 
death among Mexican-Americans [1, 2].  Within the Mexican-
American population, women aged 20 years or older have a 
greater prevalence of CVD than do men of the same age group 
[2].  Some of the known risk factors for CVD include the 
presence of diabetes, hypertension, smoking, old age, and 
dyslipidemia [3, 4].  It has been found in several studies that 
Hispanics have higher levels of several CVD risk factors when 
compared with non-Hispanic Whites [5, 7-9].  However, relative 
to non-Hispanic Whites, Mexican-Americans are 10% less likely 
to have heart disease and 30% less likely to die from heart 
disease [6]. Moreover, it is estimated that 31% of Mexican-
Americans have metabolic syndrome [8] and 40% are obese [9]. 
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The metabolic syndrome is a cluster of metabolic abnormalities 
associated with increased risk for diabetes and CVD [10].  
According to the National Cholesterol Education Program Adult 
Treatment Panel III (NCEP ATP III) the metabolic syndrome can 
be defined as the presence of three or more of the following risk 
factors: abdominal obesity, hypertriglyceridemia, low HDL 
cholesterol, hypertension, and/or fasting hyperglycemia [10].  
The metabolic mechanisms leading to a clustering of the above 
mentioned risk factors is unknown, but it is often related with 
having excess body fat and metabolic susceptibility [11].  
Moreover, increased adiposity is related to insulin resistance and 
associated metabolic abnormalities [12]. 
 
Data from the National Health and Nutrition Examination Survey 
(NHANES) shows that the prevalence of the metabolic syndrome 
in the Hispanic population in the United States is 31% [13], 
which is higher than that of non-Hispanic whites (22%) [8].  
Among Mexican-American adolescents, the prevalence of 
metabolic syndrome is 5.6% [14].  Regarding individual 
components of the metabolic syndrome, a study by Ford et al. 
[13] revealed that Mexican-Americans, when compared with 
Whites and African Americans, have the highest prevalence of 
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abdominal obesity (45.7%), hypertriglyceridemia (37.7%), and 
fasting hyperglycemia (20.0%). 
 
Health disparities refer to differences in the prevalence of a 
given disease among ethnic groups that cannot be attributed to 
biological factors [15]. Among Mexican Americans, these non-
biological factors include poverty, neighborhood environment, 
food access, level of education, acculturation, racism, 
discrimination, and stress [16-20].   
 
Lower income and education have been associated with a 
greater risk of coronary heart disease [18].  Moreover, 
inhabitants of lower socioeconomic communities tend to have a 
higher prevalence of obesity and obesity related disorders [17-
20].  One study found a negative correlation between individual 
socioeconomic status and BMI [17].  Furthermore, racially and 
ethnically diverse communities have a greater potential for lower 
dietary quality and its associated health risks and outcomes 
including obesity and obesity related disorders such as diabetes 
and CVD [18].  Larson et al. [19] suggested that individuals with 
better neighborhood access to supermarkets and a more limited 
access to convenience stores tend to have healthier diets and 
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lower levels of obesity. Low socioeconomic status has been 
suggested to increase diabetes risk due to a variety of factors 
including poor access to care, neglect of preventive strategies, a 
lower ability to exercise or an unhealthy diet [21].  The 
underlying question to these studies is whether the increased 
susceptibility to CVD or type 2 diabetes is caused by genetic or 
social factors or a combination of both. 
 
Acculturation and length of residence in the U.S. have also been 
associated with increased risk for CVD and metabolic 
abnormalities [22].    Greater acculturation has been reported to 
negatively affect diet.  For example, among Mexican-Americans, 
greater acculturation has been correlated with lower fruit and 
vegetable consumption [23].  One study found that Latinos 
consumed significantly more fruits and vegetables (33 
times/week) compared with non-Latinos (28 times/week) 
suggesting that the American culture does not support a diet 
high in fruits and vegetables [23].  Therefore, as the Mexican-
American population becomes more acculturated their newly 
acquired dietary habits may increase their risk for CVD. 
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The metabolic abnormalities associated with non-biological risk 
factors for chronic disease are in part a result of their effects on 
dietary habits.  Research has suggested that living in low 
socioeconomic and ethnically diverse communities contribute to 
the difficulty of obtaining nutritious foods that can counteract the 
effects and reduce the risk of CVD [24].  The mean quality of the 
fresh fruit and vegetable produce available in lower 
socioeconomic areas has been reported to be lower than in 
higher socioeconomic areas [25].  Lower income communities 
also tend to have fewer stores and markets that sell fresh fruits 
and vegetables [26].  Without having access to healthy foods 
such as fruits and vegetables, individuals cannot positively 
change their diets [27, 28]. 
 
Despite some indication that non-biological risk factors 
negatively affect diet and chronic disease risk, specific 
information among Mexican-Americans is scarce.  Moreover, it is 
difficult to generalize the findings of prior studies to the Mexican-
American population of the Phoenix metropolitan area due to 
differing environmental factors that may have contributed to the 
results of prior studies.  Therefore, the purpose of this 
preliminary study is to conduct an initial assessment of the 
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effects of non-biological factors and diet on cardiometabolic risk 
among Mexican-Americans living in metropolitan Phoenix.  This 
will be done by estimating the associations between biological 
contributors of cardiometabolic risk (waist circumference, BMI, 
glucose, lipids, high sensitivity C-reactive protein [hsCRP]), diet 
composition, and non-biological risk factors (income, 
employment, acculturation, education). 
 
Research Aim 
The purpose of this work was to perform a cross-sectional 
evaluation of self-reported individual and family dietary and 
lifestyle habits, sociocultural factors (income, employment, 
acculturation, and education) and biological markers of 
cardiometabolic risk among Mexican-American adults living in 
the Phoenix metropolitan area. 
 
Hypotheses 
Hypothesis 1: 
Income, employment, and education, are negatively associated 
and acculturation is positively associated with cardiometabolic 
risk factors among Mexican-American adults living in the Phoenix 
metropolitan area. 
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Specific Aim 1: 
To explore whether income, employment, education and 
acculturation affect cardiometabolic disease risk factors (lipids, 
glucose, blood pressure, insulin resistance, hsCRP, waist 
circumference) in Mexican-American adults living in the Phoenix 
metropolitan area. 
 
Hypothesis 2: 
Income, employment, and education, will be negatively 
associated and acculturation will be positively associated with 
intake of macronutrients known to adversely affect 
cardiometabolic risk (total fat, saturated fat, trans fat, simple 
carbohydrates) in Mexican-American adults living in the Phoenix 
metropolitan area. 
Specific Aim 2: 
To examine whether income, employment, education and 
acculturation affect dietary intake of macronutrients known to 
adversely affect cardiometabolic risk among Mexican-American 
adults living in the Phoenix metropolitan area. 
Specific Aim 3: 
To examine whether macronutrient intake is associated with 
cardiometabolic disease risk factors. 
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Definition of Terms 
abdominal obesity: the accumulation of visceral fat in the trunk 
region of the body, resulting in an increased waist 
circumference.  The measurements of waist circumference 
indicating abdominal obesity are >102 cm (men) and >88 cm 
(women) 
acculturation: the exchange or adaptation of different cultures 
resulting from living or associating with others from different 
cultures 
dyslipidemia: an elevation of lipids in the blood 
fasting hyperglycemia: blood glucose concentrations after fasting 
for 8-14 hours >100mg/dl 
health disparities: differences between populations in the 
prevalence of diseases, access to health care, and final health 
outcomes 
hsCRP: high sensitivity C-reactive protein used as a marker for 
inflammation and infection.  Normal values: <1.0 mg/L, 
moderately high values: 1.0-3.0 mg/L, elevated values: >3.0 
mg/L. 
hypertension: elevated blood pressure indicated by  > 130 mm 
Hg for systolic and > 85 mm Hg for diastolic 
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hypertriglyceridemia: fasting triglyceride concentrations 
exceeding 150 mg/dl 
low HDL: the concentration of cholesterol in high density 
lipoprotein <40 mg/dl (men) and <50 mg/dl (women) 
metabolic syndrome: The metabolic syndrome is a cluster of 
various risk factors of metabolic origin that contribute to the 
development of atherosclerotic cardiovascular disease.  As 
defined by NECP ATP III, it occurs when there is the presence 
of three or more of the following risk factors:  
1) abdominal obesity defined as waist circumference >102 cm 
in men and >88 cm in women,  
2) hypertriglyceridemia: >150 mg/dl,  
3) low HDL: <40 mg/dl in men and <50 mg/dl in women,  
4) hypertension: > 130 mm Hg systolic and > 85 mm Hg 
diastolic, and  
5) fasting hyperglycemia: >100mg/dl. 
socioeconomic status: a person’s standing within the community 
based on monthly income, education level, employment, and 
social status.  
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Delimitations 
This cross-sectional study focused on the non-biological factors 
that may contribute to increased CVD risk among Mexican-
Americans.  These include income, employment, acculturation, 
and education.  This study was limited to Mexican-American 
adults free of chronic diseases living in the Phoenix metropolitan 
area. 
 
Limitations 
This study had a cross-sectional design which does not explore 
the long term effects of today’s lifestyles.  The study involved 75 
adults, which may limit the statistical power relative to larger 
observational studies. 
 
Limitations include the possibility of the participants having self-
reported incorrect data on the food frequency questionnaire and 
survey.  Study procedures took approximately 1.5 hours, which 
may have been tiring, resulting in participants replying 
inaccurately due to the fact that they lost interest in the survey.  
This study did not include the study of children and adolescents 
and the affect of their lifestyle on CVD or metabolic risks later in 
life. 
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There is always risk of bias since information was gathered by 
multiple people.  However, training of interviewers prior to data 
collection decreased this risk.  Our study only included those 
contacted via newspaper, flyers, e-mail, and phone since these 
were the methods used for recruitment.  Therefore, the results 
may not truly represent all of the Mexican-Americans in the 
Phoenix metropolitan area. 
 
Furthermore, this study only focused on the Phoenix 
metropolitan area and may not be able to be generalized to 
other areas of the country.  This study was limited in the number 
of non-biological factors evaluated.  For example, non-biological 
factors that were not focused on in this study include 
environment of residence (access to food, recreation, etc.), 
racism, stress, and perceived discrimination. 
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REVIEW OF LITERATURE 
Introduction 
Hispanic is a general term to describe the ethnicity of those from 
Mexico, Central America, or South America.  Mexican-American 
is a more specific term referring to those Hispanics who either 
originated from Mexico themselves or their parents, 
grandparents, or ancestors originated from Mexico.  Some 
studies group all Hispanics together and evaluate them as a 
whole.  Others look specifically at Mexican-Americans.  
Therefore, in citing studies the term that has been used in the 
study to describe their participants has also been used here in 
this document. 
 
Hispanics are the largest minority in the United States and 
continue to grow [29].  According to the 2005 Census Bureau 
Report, 14% of the US population is Hispanic.  Hispanics are 
responsible for half of the US population growth for that year 
[29].  
 
Cardiovascular disease (CVD) is the number one cause of death 
in the United States [2]. The American Heart Association [2] 
13 
 
estimates that in 2007 over 80 million American adults have one 
or more forms of cardiovascular disease (CVD), and that 33.6% 
of all deaths were related to CVD.  Among Mexican-Americans, it 
is estimated that 26.9% of all male deaths and 31.1% of all 
female deaths are caused by CVD [2].  Even though non-
Hispanic White males and females have a higher prevalence of 
deaths from CVD (32.7% vs. 26.9%, 34.5% vs. 31.1%; 
respectively) it is still the number one cause of death among 
Mexican-Americans [2].  
 
Unlike among other ethnic groups, Mexican-American women 
have a higher prevalence as well as a higher rate of mortality 
from CVD than men [2].  This may be due to the fact that many 
Mexican-American men have low skill jobs requiring more 
manual labor which allow them to be more physically active 
during the day versus a non-Hispanic White man who may have 
a high skill job working at a desk doing little or no physical 
activity at work [30]. 
 
It has been found in several studies that Hispanics have higher 
concentrations of CVD risk factors when compared with non-
Hispanic Whites [8, 31].  Similar observations have been 
14 
 
reported in Mexican-Americans relative to other Hispanic groups 
[5].  Relative to Dominican Americans, Puerto Rican Americans, 
and all other Hispanic Americans combined, Mexican-Americans 
had the highest fasting glucose, insulin, triglyceride, and C-
reactive protein (CRP) concentrations as well as the greatest 
body mass index (BMI) [5].  This group also had the highest 
prevalence of metabolic syndrome, diabetes mellitus, and 
dyslipidemia.  Furthermore, Mexican-Americans had the second 
highest concentration of LDL cholesterol and the lowest 
concentration of HDL cholesterol [5]. 
 
When examining the studies that have been done on CVD, those 
involving Mexican-Americans specifically are very meager.  
There is even concern that studies done with Hispanics in 
general may be misleading due to inaccurate instrumentation or 
data collection [32].  Furthermore, studies that included multiple 
ethnicities of Hispanics (e.g. Cuban, Mexican, Puerto Rican, etc) 
found differences in CVD risk among different ethnic groups [5, 
33, 34].  Whether these differences can be in part attributed to 
the individual sociocultural characteristics of these individual 
Hispanic groups remains to be better understood.  Therefore, 
more research is needed with regard to Mexican-Americans 
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specifically in order to better understand the factors that 
contribute to CVD risk in this group. 
 
Cardiovascular Disease 
Cardiovascular disease (CVD) is a term used to define conditions 
that affect the heart and blood vessels [2].  CVD can be 
classified as one or more of five different forms: hypertension, 
coronary heart disease (CHD), stroke, rheumatic heart disease, 
or congestive heart failure.  CVD has been the number one 
factor for mortality for men and women in the US for the last 
nine decades [2].  As such, it is a growing concern as to why in 
the last nine decades and with the medical technology of today 
we are unable to decrease its prevalence and what changes must 
be made in order to have a healthier nation. 
 
CHD results from a slowed, impeded, or blocked blood vessel 
that prevents adequate blood flow to the heart.  Most commonly 
this is caused by atherosclerosis [35, 36].  Atherosclerosis is the 
hardening and narrowing of blood vessels.  The physical 
characteristics of the inner linings of the arteries are modified 
and change as a result of an inflammatory response, formation 
of a connective tissue matrix, or the buildup of lipid and 
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cholesterol, also known as plaque [35, 37-39].  If an artery is 
damaged or injured, platelets attach to the wall of the artery and 
release a growth hormone.  This growth hormone also promotes 
buildup on the artery wall and the development of lesions on the 
inner lining of the artery [35]. 
 
The development of atherosclerosis has been divided into 5 
phases [37-39].  Phase 1 consists of a fatty streak.  Fatty 
streaks do not block or impede the blood flow and are often the 
result of injury as aforementioned.  Phase 2 is defined by plaque 
containing a high concentration of lipids.  Often this plaque 
makes the artery more susceptible to rupture.  Phase 3 is 
characterized by lesions that rupture.  The plaque has not 
reached the size that threatens blood flow.  When plaque does 
reach the state of impeding blood flow it is considered Phase 4.  
These lesions are also prone to rupture.  Phase 4 is often also 
associated with chest pain, myocardial infarction (MI), or even 
death.  If the plaque lesion progresses to almost completely or 
fully obstructed, it is considered Phase 5.  This phase is also 
associated with chest pain, MI, and death [35, 37, 38]. 
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Atherosclerosis often leads to endothelial dysfunction, 
characterized by the inability of the blood vessels to constrict 
and dilate properly in order to meet demands due to the buildup 
of plaque and injury to blood vessels [35, 36, 39, 40].  This can 
result in increased myocardial stress [41, 42], increased risk for 
myocardial infarction or stroke [43], increased vascular stress 
[41], ischemic and hemorrhagic complications such as rupture 
[44], an increased severity of sleep apnea [45, 46], and organ 
damage [47, 48]. 
 
Lipoproteins 
Blood lipids such as cholesterol, triglycerides, and phospholipids 
are transported in the blood as part of three-dimensional 
structures called lipoproteins.  Each lipoprotein varies in its size, 
composition, and density.  The composition consists of a center 
core, made up of triglycerides and cholesterol, and surface, 
made up of phospholipids and apoproteins [49].  The functions 
of apoproteins are to ensure structural stability, establish the 
metabolic outcome of the particles on which they are located, or 
act as cofactors for enzymes that function to metabolize plasma 
lipids and lipoproteins [49]. 
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The density is determined by the amount of protein or lipids in 
the particles.  Therefore, a high-density lipoprotein (HDL) has 
more protein than lipids in its composition.  On the other hand, 
low-density lipoproteins (LDL) are made up of less protein and 
more lipids [35]. 
 
In humans, LDL cholesterol carries the majority of the 
cholesterol in the blood.  Since total cholesterol measurements 
reflect the total amount of cholesterol being carried by all 
lipoproteins (HDL, LDL, and triglycerides), total cholesterol and 
LDL cholesterol are positively correlated.  Furthermore, LDL 
cholesterol can be oxidized and taken up into the arterial wall by 
macrophages and endothelial cells.  When LDL is taken up into 
the wall it promotes lesion and plaque formation.  As a result, 
LDL contributes to atherosclerosis advancement [35].   
 
HDL cholesterol originates from precursors which have been 
synthesized in the liver and small intestine.  Commonly, the 
main function of other lipoproteins is to transport lipids to the 
cells.  However, HDL cholesterol removes excess cholesterol 
from peripheral cells and transports it to the liver in order to 
maintain the cellular cholesterol homeostasis [50, 51].   
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Macrophages are phagocytes that take up dead and dying cells 
as well as aggregated and modified lipoproteins.  Both types of 
lipoproteins and cells contain profuse cholesterol.  However, too 
much cholesterol can be toxic, resulting in a need to efflux the 
cholesterol into the extracellular environment.  The most 
commonly studied pathway of cholesterol efflux is through the 
ABCA1 transporter which causes cholesterol efflux to the lipid-
poor apoA-1 [52].   
 
Enterocytes and hepatocytes synthesize apoA-1, which is 
synthesized and secreted by the liver and intestine in a lipid-
poor form, and then immediately engage additional 
phospholipids and free cholesterol via the ABCA1 pathway, 
forming pre-β HDL [52, 53].  This nascent HDL obtains more 
lipid from other peripheral tissues and from lipoproteins, after 
which lecithin-cholesterol acyltransferase (LCAT) transforms it 
into cholesterol ester.  The result is mature HDL [52].  HDL 
transports the cholesterol that has been effluxed to the liver.  
After the cholesterol is delivered to the liver it is catabolized and 
excreted.  This process is known as the reverse cholesterol 
transport (RCT) [52-55]. 
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There are three stages of the reverse cholesterol transport: 
extravascular, intravascular, and intrahepatic.  The extravascular 
phase involves unesterified cholesterol being removed from cell 
membranes by the apoprotein A-1 (apo A-1) found in the 
interstitial fluid [54].  The unesterified cholesterol enters the 
blood via the peripheral lymph which begins the intravascular 
phase.  During this phase the cholesterol is esterified by lecithin-
cholesterol acyltransferase (LCAT).  Once esterified, some of the 
cholesterol is transferred to chylomicrons and VLDL by a transfer 
protein [54].  The rest are integrated into the center of the HDL 
particles causing them to increase in size and decrease in 
density.  During the intrahepatic phase the cholesterol esters are 
removed from the circulation through the direct transfer of the 
esters from the HDL particles into the liver cells.  Cholesterol is 
then eliminated by hepatocytes by secretion into the bile [54]. 
 
High HDL concentrations are correlated with lower CVD and 
atherosclerosis risk [35].  Other anti-atherogenic properties of 
HDL include the inhibition of LDL oxidation, inhibition of 
endothelial inflammation, promotion of endothelial nitric oxide 
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production, promotion of prostacyclin bioavailability, and 
inhibition of platelet aggregation and coagulation [52]. 
 
Considering that LDL is directly involved in plaque formation and 
atherosclerosis, LDL cholesterol concentrations are a better 
indicator of CVD risk than total cholesterol [10, 56-59].  Several 
studies look specifically at LDL and its relationship with CVD or 
atherosclerosis [10, 56-59].  Few studies explore the relationship 
between total cholesterol and CVD.  One reason is due to the 
fact that concentrations of HDL cholesterol and triglycerides will 
also affect total cholesterol.  For example, an elevated HDL 
cholesterol concentration is desirable due to its protecting 
properties.  However, an elevated HDL concentration may also 
elevate the total cholesterol.  Furthermore, studies have shown 
that LDL-lowering treatments reduce the risk for CVD [10, 56-
59].  Seeing the effect that one lipid has on another reiterates 
the fact that it is important to analyze CVD risk based on all of 
the lipid profiles and not just one [60]. 
 
Cardiovascular Disease Risk Factors 
CVD risk can be associated with either lifestyle factors or 
biological factors.  Some risk factors include those that have 
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proven interventions that result in a decrease in risk.  Examples 
include high LDL cholesterol concentrations, hypertension, and 
cigarette smoking [34, 61-63].  Others include risk factors for 
which interventions are likely to decrease risk such as diabetes, 
physical inactivity, low HDL cholesterol concentration, and 
obesity [7, 8, 31, 33, 61-66].  Risk factors where more research 
is needed in order to determine if the intervention will lower the 
risk are risk factors such as psychosocial factors, elevated 
triglyceride concentrations, C-reactive protein, and oxidative 
stress [5, 7, 31, 33, 61, 62, 66, 67].  Lastly, risk factors that 
cannot be changed or modified with interventions consist of age, 
gender, ethnicity, and family history [5, 7, 31, 33-35, 61, 62, 
65-71]. 
 
Additional biological factors that increase the risk for developing 
CVD include elevated concentrations of total cholesterol and 
fasting blood glucose because these factors contribute to the 
buildup of plaque in the arteries that can lead to atherosclerosis 
[36, 39, 40, 72]. 
 
Total cholesterol concentration is an independent risk factor of 
atherosclerotic plaque development [8, 13, 65, 73].  According 
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to a study by Kerenyi et al. [73], people with lower total 
cholesterol concentrations had significantly less plaque when 
compared with those who had any amount of carotid artery 
plaque buildup or lesions [74, 75]. 
 
As cholesterol attaches to the inner lining of the artery and 
plaque and lesions form, an inflammation response occurs.  
Damage occurs in the cells due to the inflammation.  C-reactive 
protein (CRP) is then stimulated since its primary function is to 
attach to the plasma membrane of a damaged cell and cause 
death to that cell through the complement cascade [76].  Thus, 
CRP is a good indicator of inflammation and possible 
atherosclerosis progression.  Elevated CRP concentrations (> 3.0 
mg/L) have been found to be positively associated with having a 
high risk of developing CVD and a risk of future cardiovascular 
events such as myocardial infarction and stroke. [77-79]. 
 
Weight, specifically the body mass index (BMI), is positively 
associated with an increased risk for CVD and CHD [31, 65, 69].  
Obese participants (BMI ≥ 30 kg/m2) have more CVD risk factors 
when compared to persons with a normal BMI (18.5-24.9 kg/m2) 
[7, 13, 33, 65, 69].  Similarly, persons considered obese had 
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significantly higher blood pressure than those considered to have 
a normal BMI [8, 13, 31, 33, 34, 65, 80].  HDL cholesterol is 
negatively correlated with BMI, and triglycerides have a 
significantly positive correlation with BMI [33, 69].  Obese 
persons are 1.5 times more likely to die from complications due 
to cardiovascular disease than persons who are normal weight 
[8, 31, 69, 80]. 
 
Abdominal obesity is also associated with increased risk for CVD 
[81-85].  There is a positive association with waist circumference 
and CVD [83, 84, 86, 87].  Those who have a waist 
circumference greater than the recommended measurement 
(>102/88cm for men/women) were 1.25 times more likely to 
develop CVD [81, 82, 87].  A clustering of 1-2 factors for 
metabolic syndrome including waist circumference above 
recommendations doubled the risk for CVD [86].  Persons with 
the metabolic syndrome (clustering of 3 or more factors) 
including waist circumference above recommendations had 2.5 
times the risk for developing CVD [86]. 
 
Elevated blood glucose concentrations have also been associated 
with an increased risk for developing CVD [13, 70, 80].  
25 
 
According to Nakagami et al. [70], 2-hour plasma glucose and 
fasting plasma glucose concentrations are positively associated 
with all-cause mortality and CVD.  A person with an elevated 2-
hour plasma glucose or fasting plasma glucose concentration has 
a 1.14 and 1.24 increased risk for all-cause mortality or CVD 
mortality [70].  The results from one study show that persons 
dying from coronary heart disease or stroke have a significantly 
higher serum glucose concentration than those not dying from 
CVD (p=0.024) [13].  Another study reports that impaired 
fasting or impaired 2-hour glucose concentrations resulted in a 
1.31 increased risk of mortality [80]. 
 
During a prolonged hyperglycemic state, there is a conversion of 
the reversible Schiff base adducts to more stable Amadori 
rearrangement products [87, 88].  With time, these Amadori 
products continue to experience further rearrangement reactions 
and ultimately form the permanently bound advanced glycation 
end products (AGE).  AGEs form as a result of the non-enzymatic 
reaction between reducing sugars and biological proteins [88, 
89].  AGEs have been found within atherosclerotic lesions in both 
extra and intracellular sites [90].  Furthermore, high 
concentrations of the AGE receptor (RAGE) have been associated 
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with an increased inflammatory reaction in the plaque 
macrophages of atherosclerosis [91].  In a study by Semba et al. 
[92], 17% of those who died from CVD had the highest 
concentration of plasma AGE (p=0.001). 
 
AGEs that form on the extracellular matrix cause a decrease in 
the elasticity of the vasculatures [88].  The AGEs also reduce the 
nitric oxide.  As a result, the endothelium vasodilation is 
compromised and unable to perform accurately as needed [88].  
Furthermore, the reduced or diminished nitric oxide, resulting 
from the oxidative stress caused by the AGEs, forms 
peroxynitrite.  This in turn causes more endothelial cell damage 
and even platelet activation [88].  In addition, AGEs are capable 
of stimulating osteoblastic differentiation of microvascular 
pericytes.  These ultimately add to the progression of vascular 
calcification in atherosclerosis [88]. 
 
Cardiovascular Disease Risk Factors Among Hispanics 
As aforementioned, it is estimated that 30% of Mexican-
American males and females have at least one form of CVD [2].  
Biological risk factors include but are not limited to a person’s 
lipid profile, fasting glucose concentrations, and insulin 
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concentrations, as well as a person’s BMI, waist circumference, 
and blood pressure.  Mexican-Americans have been shown to 
have more biological and anthropometric risk factors when 
compared to both non-Hispanic Whites and other Hispanics. 
 
Regarding CVD risk, Hispanics have 15% higher concentrations 
of triglycerides when compared to non-Hispanic Whites 
(p<0.001) [7, 31, 61, 67].  Furthermore, Hispanics have 
significantly lower HDL cholesterol concentrations (49.5 mg/dL 
vs. 55.3 mg/dL, p<0.001) [7, 31, 61, 65] and significantly 
higher glucose concentrations (107 mg/dL vs. 104 mg/dL; 
p=0.04) [7, 67] relative to non-Hispanic Whites.  Similarly, 
insulin concentrations are also higher in Hispanics when 
compared to non-Hispanics (11.2 µU/mL vs. 9.3 µU/mL) [7, 65]. 
 
In comparing Mexican-Americans with other Hispanic-American 
ethnicities (Dominican Americans, Puerto Rican Americans, Other 
Hispanic Americans), Mexican-Americans have a higher mean 
value when exploring various risk factors for developing CVD, 
such as BMI (30.0 kg/m2 vs. 27.9 kg/m2, 29.7 kg/m2, or 28.6 
kg/m2, respectively), glucose (112.9 mg/dL vs. 105.1 mg/dL, 
110.6 mg/dL, or 110.3 mg/dL, respectively), insulin (8.7 mU/L 
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vs. 6.5 mU/L, 7.7 mU/L, or 7.7 mU/L, respectively), percent of 
participants having the metabolic syndrome (49.1% vs. 33.2%, 
37.9%, or 37.6%, respectively), percent of participants having 
diabetes (22.3% vs. 16.1%, 19.7%, or 15.2%, respectively), 
triglyceride (173 mg/dL vs. 125 mg/dL, 134 mg/dL, or 147 
mg/dL, respectively), low HDL cholesterol (46 mg/dL vs. 48 
md/dL, 49 mg/dL, or 50 mg/dL, respectively), percent of 
participants having dyslipidemia (41.1% vs 36.9%, 33.4%, or 
33.0%, respectively), and hsCRP (4.33 mg/L vs. 3.41 mg/L, 
4.14 mg/dL, or 3.92 mg/dL, respectively) [5, 34].  All non-
Mexican-American Hispanics had a significantly lower prevalence 
of atherosclerosis (OR=0.63, 95% CI: 0.45, 0.90) [5].  
Furthermore, Mexican-Americans were twice as likely to develop 
aortic plaque buildup when compared with other non-Mexican-
American ethnicities [5]. 
 
Metabolic Syndrome 
The metabolic syndrome is a cluster of metabolic abnormalities 
associated with an increased risk for diabetes and CVD [10].  
According to the National Cholesterol Education Program Adult 
Treatment Panel III (NCEP ATP III) the metabolic syndrome can 
be defined as the presence of three or more of the following risk 
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factors: abdominal obesity, hypertriglyceridemia, low HDL 
cholesterol, hypertension, and/or fasting hyperglycemia [10].  
Abdominal obesity is the accumulation of visceral fat in the trunk 
region of the body, resulting in an increased waist 
circumference.  Per NCEP ATP III definition [10], abdominal 
obesity is classified as waist circumference measurements >102 
cm (men) and >88 cm (women).  Hypertriglyceridemia is 
defined as fasting triglyceride concentrations ≥150 mg/dL.  Low 
HDL cholesterol is considered a concentration of cholesterol in 
high density lipoprotein <40 mg/dL (men) and <50 mg/dL 
(women).  Hypertension, or elevated blood pressure, is indicated 
by ≥130 mm Hg for systolic and ≥85 mm Hg for diastolic.  
Fasting hyperglycemia consists of blood glucose concentrations 
after fasting for 8-14 hours that are ≥100 mg/dL [93, 94].  
 
The metabolic mechanisms leading to a clustering of the above 
mentioned risk factors are unknown, but it is often related with 
having excess body fat [11].  Moreover, increased abdominal 
adiposity is related to insulin resistance [7, 8, 12, 31, 65-67].  
Insulin resistance, which ultimately results in hyperglycemia, is a 
major factor in the development of type 2 diabetes.  
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A frequent or constant hyperglycemic state can result in damage 
to arteries, veins, and organs, including the heart.  High 
concentrations of glucose in arteries, both macrovascular and 
microvascular, result in a significant decrease in a cell’s function 
and also their growth ability [95].  Furthermore, hyperglycemia 
will also significantly increase the occurrence of cell apoptosis 
when compared to normal glucose concentrations [95].  As a 
result, uncontrolled levels of glucose concentration in the blood 
are positively associated with CVD and macrovascular events 
[96, 97]. 
 
National surveillance data indicates that individuals with the 
metabolic syndrome have three times greater incidence of CVD 
than those without the syndrome [8, 13, 98].  Cardiovascular 
mortality is also increased in people with the metabolic 
syndrome [13, 98], and those with the metabolic syndrome are 
found to be two times more likely to die from CVD or 
complications related to CVD than those without the metabolic 
syndrome [8, 80].  Among people with the metabolic syndrome, 
the highest percent of people (10%) had a combination of 
obesity and dyslipidemia or obesity and hypertension [13, 98].  
Furthermore, Hispanics have a significantly higher prevalence of 
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clustering of the metabolic syndrome factors (63% in Hispanics 
vs. 30% in non-Hispanic Whites) when compared to non-
Hispanic Whites [67, 99].  A person’s risk for developing CVD 
increases as the number of clustering factors increases [8, 13, 
80, 100]. 
 
Health Disparities 
Many ethnicities, including Mexican-Americans, have a higher 
prevalence for certain diseases that cannot be explained 
biologically.  Furthermore, some barriers may also prevent them 
from receiving treatment that they need and deserve [7, 100-
112].  However, it is important to realize the prevalence of 
disease for different ethnicities in order to prevent the disease 
and not just treat the disease.  In regard to the prevalence of 
CVD risk factors among Hispanics or Latinos, 21.5% have 
hypertension, 8.5% have heart disease, 5.8% have coronary 
heart disease, and 2.0% have had a stroke [2]. 
 
Health care, in all its forms, is an important factor in determining 
a person’s risk of developing chronic disease and also quality of 
life.  It is also important to evaluate the type and quality of care 
a person may receive, their understanding of any problems 
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and/or treatment, and their satisfaction with the care.  Non-
Hispanics have a greater utilization of health care services such 
as general physical examinations, eye exams, and dental 
checkups than Hispanics [101, 102].  Mexican-Americans have 
several barriers that may prevent them from receiving the 
quality of care that they both want and deserve.  These barriers 
include: income to pay for health care visits, health insurance, 
language, location/neighborhood, cultural beliefs, ethnicity, and 
lower expectations of health care [7, 100, 101, 103-112].  
 
Language may be a significant barrier since the patient needs to 
explain to the health care provider their concerns, symptoms, 
and observations.  Likewise the health care provider needs to be 
able to communicate back to the patient in order to explain 
diagnosis and treatment options as well as answer questions that 
may arise.  There is a negative association between language 
spoken and satisfaction such that those who speak primarily 
Spanish have a less satisfying health care experience than those 
who speak English [101, 103, 104]. 
 
Mexican-Americans are more likely to live in neighborhoods that 
have a high population of Hispanics.  When comparing 
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communities that have comparable socioeconomic statuses, 
communities that are primarily Hispanic had significantly less 
physicians than those neighborhoods that were predominantly 
non-Hispanic White [107].  Being an ethnicity that is considered 
a minority is also associated with a higher prevalence of health 
problems and a poorer health status [113-115]. 
 
When compared to non-Hispanic Whites, Mexican-Americans are 
more than two times as likely to have a lower socioeconomic 
status and lower income level [7, 100, 108-110].  They are also 
more likely to have jobs that do not offer health insurance [110-
112].  A greater number of Hispanics are uninsured when 
compared to non-Hispanics, a number that is associated with 
income [108, 110-112, 115].  Lack of health insurance creates a 
barrier to receiving health care services and also needed 
prescription medications [102, 104, 110, 115-118]. 
 
Another barrier that Mexican-Americans have is their cultural 
beliefs and traditions that may affect their reception of health 
care and treatment.  For example, there are certain holidays, 
foods, and traditions that Mexican-Americans have celebrated for 
decades or even centuries and consider important. A healthcare 
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provider belittling or degrading such traditions in the name of 
health, no matter how right they may be that the tradition is 
unhealthy, may offend the patient and discourage them from 
returning for more treatment later.  On the other hand, 
healthcare providers that respect Mexican-American traditions 
and culture may impress the patient who is more likely to return 
for more treatment later [104, 118-120].  Some Hispanics also 
have beliefs that self-medication and other “home remedies” can 
be more effective at treating disease than prescriptions or 
treatments they could receive from their doctor or health care 
provider [119, 120].   
 
Social Determinants of Cardiovascular Disease Risk 
Aside from the known biological conditions leading to chronic 
diseases such as CVD and diabetes, research has shown that 
non-biological factors also contribute to these diseases.  These 
non-biological factors include poverty, neighborhood 
environment, food access, level of education, acculturation, 
racism, discrimination, access to healthcare, language barriers, 
and stress [16-20, 121].  Lower income and education have 
been associated with a greater risk of coronary heart disease 
[18, 34, 61, 71, 122-124].  Moreover, inhabitants of lower 
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socioeconomic communities tend to have a higher prevalence of 
obesity and obesity related disorders [7, 17-20, 125-130]. 
 
Mexican-Americans have a significantly lower level of education 
and income than non-Hispanics [7, 100, 109].  As a result, they 
are more likely to live in neighborhoods that are not conducive 
to physical activity and that do not have access to healthy food 
[125, 130-132].  Furthermore, lower income individuals or 
persons living in poverty may not have health insurance or funds 
in order to receive proper healthcare from a qualified 
professional [109, 133, 134].  As aforementioned, Mexican-
Americans who have recently migrated to the United States may 
face a language barrier that prevents them from receiving 
desired services or from knowing where to find healthy food 
options. 
 
Socioeconomic Status 
One predictor of a person’s quality of life and a person’s risk for 
developing chronic diseases such as CVD is their socioeconomic 
status [122, 123, 125, 127-130, 135, 136].  Socioeconomic 
status influences the likelihood that a person may or may not 
have the funds to buy healthy foods, receive medical treatment, 
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or pay for needed medications.  It can also affect where a person 
lives and whether or not that environment has access to healthy 
foods, healthcare facilities, pharmacies, or areas conducive for 
physical activity.  Since socioeconomic status has significant 
effects on the prevention, diagnosis, and treatment of disease, 
and because Mexican-Americans are more likely to live in lower 
SES areas, it is important to explore its impact on Mexican-
Americans [7, 125, 135].  Although there are several factors to 
consider when exploring socioeconomic status, the only areas 
that will be covered in this section are education and income. 
 
Education 
Education is an ideal socioeconomic variable for use in studies 
because it is a factor that all participants will have regardless of 
their employment, age, gender, or marital status [135].  It also 
has a high level of validity and reliability.  Furthermore, 
education is less likely to change after early adulthood, is easily 
reported, and can be a continuous variable as opposed to other 
variables such as income, age, and marital status that may vary 
during life [135].  Education can also affect a healthy lifestyle in 
that it influences life-style behaviors, access to health services, 
and higher self-esteem and self-efficacy [135].  Persons with 
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lower education have more associations with risk factors for 
developing cardiovascular disease when compared with those 
who have higher education [71, 122, 123, 127-130, 135, 137].  
Persons with higher education are more likely to be literate and 
use print media to learn about risks for CVD [70].  Education is 
positively associated with income [122, 130] which has an effect 
on food purchases, places of residence, and finances to pay for 
healthcare. 
 
Education has been negatively associated with CVD risk factors 
[34, 71, 99, 121, 127-129].  Hispanics who are high school 
graduates when compared to Hispanics who have graduated 
from college have higher systolic blood pressure (126±14 mm 
Hg vs. 120±15 mm Hg, p=0.004, respectively), higher percent 
who are hypertensive (39.6% vs. 18.4%, p<0.001, 
respectively), and higher mean total cholesterol (214±50 mg/dL 
vs. 196±39 mg/dL, p=0.01, respectively) [71].  Fifty percent of 
Hispanics with some high school or less have metabolic 
syndrome while 9.5% of those who are high school graduates 
and 8.1% of those who are college graduates have metabolic 
syndrome [99]. 
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In addition, there is a positive correlation between education and 
motivation to change health behavior and reduce CVD risk [71, 
138].  Education is also positively associated with use of health-
related print media [71] or attending community-based 
programs intended to help people improve their lifestyle [138].  
Hispanics, when compared to non-Hispanic Whites, are more 
likely to have less than 12 years of education [61, 71].  In 
particular, Mexican-Americans are 3 times more likely to have at 
least one risk factor for developing CVD when their education 
level is <12 years relative to Mexican-Americans who have >12 
years of education [71, 100, 122, 123, 127, 129, 130]. 
 
Income 
Regardless of race or ethnicity, the risk for developing CVD has 
been reported to be higher among those individuals with lower 
income levels [122, 124, 136].  According to the National Health 
Interview Survey (NHIS), heart disease, ischemic heart disease, 
and hypertension were negatively correlated with poverty status 
and income [9, 135].  Poverty status was scored based on the 
family/household’s total income with regard to the 
family/household size and then compared to the US Census 
Bureau’s poverty thresholds. 
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Total cholesterol concentrations are significantly higher in 
persons with a lower income level than those persons with a 
higher income level [136, 139, 140].  Furthermore, income is 
negatively associated with waist circumference, blood pressure, 
serum glucose levels, and triglyceride concentrations [127, 140-
142].  In addition, LDL cholesterol concentrations and C-reactive 
protein are negatively associated with income while HDL 
cholesterol concentrations are positively correlated with income 
[129, 140, 143]. 
 
Moreover, neighborhoods with a higher median income may 
have better access to parks, better maintained roads and 
walkways, and more food options, thus resulting in more 
physical activity and decreased caloric intake [63, 121, 131, 
134].  Furthermore, households with a higher income may have 
more access to health care and medical insurance which could 
lower their risk for obesity [109, 133, 134].  Lastly, for each 
$1000 increase in median household income there is a resulted 
0.6% decrease in obesity risk [134, 137]. 
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As previously mentioned, one predictor of a person’s risk for 
developing CVD is their socioeconomic status, including income 
[122, 123, 125, 127-130, 135, 136].  When compared to non-
Hispanics, Mexican-Americans have a significantly lower income 
[7, 100, 109].  Among Hispanics, income has been negatively 
associated with BMI [130, 137].  One study looking at percent 
body fat and obesity in low-income children found that the mean 
percent body fat is greater in Mexican-American children when 
compared to non-Hispanic White children (24% vs. 17%, 
respectively; p=0.003) [144].   
 
Another study focused on prevalence of the metabolic syndrome 
among Mexican-Americans, non-Hispanic Whites, and African 
Americans [145].  The participants were compared by economic 
category (low, middle, high) and race/ethnicity.  Only 12% of 
Mexican-Americans were grouped in the highest economic 
category.  Significantly more women in the low economic 
category (34%) were classified as having the metabolic 
syndrome when compared to the middle (28%) or high (21%) 
categories (p=0.0009) [145].  When comparing women in the 
various race/ethnic groups, Mexican-Americans had a 
significantly higher prevalence of elevated glucose (19%, 
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p=0.0044), waist circumference >88cm (67%, p=0.0002), low 
HDL cholesterol (57%, p=0.0092), and elevated triglycerides 
(30%, p=0.0042) than non-Hispanic Whites or African 
Americans.  Among men, there was no significant difference 
among economic category.  Mexican-American men, when 
compared to the non-Hispanic Whites and African Americans, 
had a significantly higher prevalence of low HDL (46%, 
p=0.0006) and elevated triglycerides (42%, p<0.0001) [145]. 
 
Environment 
Access to Food 
A large contributing factor to the ability of people to have 
healthful diets and thus reduce their risk for CVD is their ability 
to access healthy foods.  Several factors can affect food access 
and fruit and vegetable consumption.  Studies have found a 
relationship between income and food access [146, 147].  The 
neighborhood where someone lives influences the number and 
type of supermarket, the quality of the products, and the cost of 
the food available [148-150].   
 
Not only does access to food involve the food environment but 
also how people adapt and live within that environment.  One 
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example is that if neighborhoods are unsafe for walking, people 
will be less likely to walk no matter the distance to their 
destination.  Furthermore, whether a household owns a car 
might have a greater importance in determining access to food 
than actual distance to the store indicating that time may have 
as much of an impact on food access as does distance and 
transportation [146]. 
 
Food environments differ by community [151].  Physical access 
to healthy food choices differs by location, and these differences 
are often patterned according to socio-demographic 
characteristics of the residence of the community [151].  For 
example, Powell et al. [152] found that all food store types are 
significantly less available among rural areas than in urban 
areas.  Furthermore, their study showed that lower income 
neighborhoods had greater access to non-chain supermarkets 
and grocery stores.  On the other hand, the urban low-income 
neighborhoods had access to more convenience stores [152].  
Another study reported that areas where predominantly 
minorities resided had a lower socioeconomic status and had 
four times more liquor stores and fewer grocery stores when 
compared to the middle socioeconomic position residents [25].  
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Additionally, chain supermarkets have lower food prices and 
higher quality food products when compared to non-chain 
supermarkets and smaller grocery stores [152]. 
 
Access to Fruits and Vegetables 
Diets consisting of a variety of fruits, vegetables, whole grains, 
and low-fat dairy foods can reduce risk for metabolic syndrome 
and CVD [153-155].  Such diets have been shown to raise HDL 
cholesterol, lower triglycerides, lower systolic and diastolic blood 
pressure, lower weight, and lower blood glucose concentrations 
[154].  One study found that less-acculturated, low-income 
Hispanics eat more fruits and vegetables than bicultural or more-
acculturated peers.  Despite this fact, 75% of all the participants 
in the study still fell short of the dietary recommendations of a 
minimum of 5 servings of fruits and vegetables per day [156]. 
 
One factor affecting the consumption of fruits and vegetables is 
distance to the supermarket.  One study found a negative 
correlation between distance to the supermarket and fruit and 
vegetable consumption [157].  However, the results were only 
significant for metropolitan areas and not for rural areas.  One 
factor may be that to travel the same distance may take longer 
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in a busy and congested urban area versus a less busy rural 
area.  Thus, supermarket accessibility measured by distance 
may be different in urban versus rural dominated environments 
[157]. 
 
In general, although people may have access to foods, the 
selection may be limited in fruits and vegetables.  Research 
showed that non-chain grocery stores were less likely to sell 
foods classified as healthy (e.g. whole wheat bread, skinless 
chicken) than chain supermarkets, and that the quality of 
produce was lower in non-chain grocery stores [158, 159].  
Results show that the store type was related to the food choices 
and the availability of those choices [159].  Chain supermarkets 
have more availability of fresh, canned, and frozen fruits and 
vegetables than independent groceries, drug stores, or 
convenience stores.  Furthermore, supermarkets (chain, 
independent, and discount) had three times as many fruits and 
vegetables available as smaller grocery stores, drug stores, and 
convenience stores [159]. 
 
Block and Kouba [159] found that the grocery stores, as 
opposed to larger supermarkets, provided produce at a 
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competitive price.  They also found that produce quality varied 
greatly between store types.  Supermarkets had higher quality 
produce whereas grocery store produce was not satisfactory 
quality.  They concluded that access to healthy food choices is 
related more to the type of store than to the number of stores in 
a given area [159]. 
 
Another study by Bodor and Rose found that mean space 
dedicated for fruits and vegetables was considerably larger for 
supermarkets than for small food stores [28].  In addition, 
supermarkets had 70% of fruit and vegetable shelf space 
available for fresh produce, where as small food stores allotted 
only 32% of their fruit and vegetable shelf space to fresh 
produce.  Moreover, supermarkets also offered a substantially 
larger variety of fresh produce than did small food stores.  
Therefore, a greater fresh vegetable availability was a positive 
predictor of vegetable intake.  However, fresh fruit availability 
was not associated with intake [28]. 
 
Individuals with a high school education or less are reported to 
have decreased access to a large selection of fruits and 
vegetables [160].  This same group was also reported to be 
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more likely to shop at convenience stores [160].  Thus, those 
with a high school education or less may not have access to 
foods that allow them to follow the aforementioned 
recommendation of consuming a diet consisting of a variety of 
fruits, vegetables, whole grains, and low-fat dairy foods which 
may reduce risk for metabolic syndrome and CVD [153-155].  
Such diets have been shown to raise HDL cholesterol, lower 
triglycerides, lower systolic and diastolic blood pressure, lower 
weight, and lower blood glucose concentrations [154]. 
 
Cost of Food and Food Quality 
Another contributing factor besides access to food is the cost of 
healthy foods when compared with energy dense foods.  Lipsky 
et al. [161] found an inverse relationship between energy 
density (defined as kcal/gram) and energy cost (defined as 
cost/kcal).  Although the total package price and unit price of 
produce were lower than those of snacks, the average per 
serving price for produce was higher than for snack foods 
($0.70±0.10/serving produce vs. $0.40±0.04/serving of snacks, 
p=0.02).  Furthermore, inner-city markets were found to charge 
more for their food than do larger chain grocery stores found in 
suburban communities [161].  Rural areas have reported 
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disadvantages when examining availability, accessibility, and 
adequacy of healthy foods [162, 163]. 
 
The Changing Individuals’ Purchase of Snacks (CHIPS) study 
[164] found that by reducing the price of low-fat snacks sold in 
vending machines by 10%, 20%, and 50%, there was an 
associated increase in low-fat snack sales.  Similarly, a study 
done in a supermarket found that by using verbal prompts, 
product sampling, and price reduction there was an increase in 
sales for lower-fat products [165]. 
 
Neighborhood 
The layout and accessibility within a neighborhood can have an 
effect on the health outcome of people living within that 
neighborhood.  Factors that have an effect include availability of 
supermarkets or other food stores that supply healthy food 
choices, parks and other recreational facilities, well maintained 
sidewalks and walkways, walkability, and street connectivity 
[134].  Walkability is the ease with which a person can walk to 
their destination, such as a store or park.  This involves the 
condition of the sidewalk, the number of busy streets to cross, 
and how close to the traffic the sidewalk is placed.  The greater 
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the walkability, the more inviting it will be for pedestrians.  
Street connectivity refers to the size of blocks, the number of 
intersections and roads to cross, and the ease or ability to get 
from one part of a community to another either in a direct 
manner or through multiple pathways [134]. 
 
There is a positive association between obesity risk and urban 
spacing [134].  Urban spacing involves the distances between 
residences and the layout of the streets [134].  Furthermore, 
there is also a positive relationship between neighborhood 
structure, including street connectivity and physical activity, and 
obesity risk [134]. 
 
In looking at different ethnic groups, Lopez [134] hypothesized 
four different neighborhood-related associations that could be 
possible factors for increasing the risk of obesity within the 
Hispanic population: 1) the potential lack of, or poorly 
maintained, infrastructure, including street lights, sidewalks, 
public transportation, or parks, might reduce physical activity; 2) 
public safety conditions or perceptions may decrease physical 
activity; 3) socioeconomic conditions or lack of private 
investment may reduce quality or availability of recreation 
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facilities or places that sell nutritious food; 4) targeted 
advertising may include less healthy consumer products. 
 
Evidence suggests that the environment in which people live can 
influence their likeliness to walk [166].  People tend to walk 
more in communities that have sidewalks in good condition with 
few obstructions, provide destinations and facilities that can be 
reached within walking distance and are free from physical 
disarray such as trash or abandoned buildings [167].  Moreover, 
individuals who live in low income and racial and ethnic minority 
communities tend to experience having less of an access to 
environmental features that support physical activity when 
compared with higher income communities [166]. 
 
Neighborhood areas that are reported by residents as safe have 
been significantly related to walking activity [167].  There is also 
a significant correlation between the number of street 
intersections and the perceptions of safety from traffic [167].  
Furthermore, residents in communities with more street 
intersections who reported being safer from traffic tended to also 
report more walking activity within their neighborhood [167].  
Another study reports that individuals who perceived that they 
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had no place to walk were significantly less healthy than persons 
who thought they had at least one place to walk [168]. 
 
Additionally, another study explored racial and ethnic disparities 
in response to direct-to-consumer advertising (DTCA) [169].  
Non-Hispanic Whites were more likely than Hispanics and African 
Americans to be exposed to DTCA.  However, Hispanics and 
African Americans are more likely to be influenced by DTCA than 
Whites [169].  Moreover, Hispanics and African Americans are 
more positive about the health benefits they are exposed to 
through DTCA [169]. 
 
Evidence from the aforementioned article by Lopez also shows 
that an increase in population density results in a decrease in 
obesity risk [134].  In addition, an increase in population density 
may be associated with greater walkability, more destinations for 
walking, increased likelihood that a person will use alternatives 
to driving, or amenities that increase the possibility that physical 
activity will take place [134].  Another study by Stark-
Casagrande et al. [170] found that individuals living in high 
socioeconomic status areas with highly walkable neighborhoods 
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had a lower prevalence of obesity when compared with people 
living in poorly walkable neighborhoods. 
 
Rundle et al. [171] conducted a study that examined the 
association of neighborhood environments with BMI and obesity.  
The results of this study were that the highest density of healthy 
food stores was located in higher-income neighborhoods [171].  
On the other hand there was a higher concentration of food 
stores that did not supply a large selection of healthy food 
choices in the lower-income neighborhoods.  Therefore, it can be 
concluded that a lower BMI and lower prevalence of obesity may 
be associated with access to healthy food stores [171]. 
 
Acculturation 
Acculturation refers to the extent that an immigrant accepts and 
adopts the beliefs, customs, and practices of the country to 
where they have relocated [172].  Acculturation and length of 
residence in the U.S. have been associated with increased risk 
for CVD and metabolic abnormalities [22].  Greater acculturation 
has been reported to negatively affect diet.  For example, among 
Mexican-Americans, greater acculturation has been correlated 
with lower fruit and vegetable consumption [23, 156]. 
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When comparing non-Hispanic Whites with Hispanics, non-
Hispanic Whites had a mean consumption of 0.87 servings of 
fruit and 0.31 servings of vegetables less than that of Hispanics 
[173-176].  Furthermore, non-U.S. born Hispanics eat 
significantly more fruits and vegetables than U.S. born Hispanics 
[173, 174].  Mexican-Americans with a lower acculturation score 
had a significantly higher daily intake of fruits and vegetables 
than Hispanics that are more acculturated (5.07 servings/day vs. 
4.70 servings per day, p<0.05, respectively) [176].   
 
In a study comparing fruit and vegetable intake of Mexican-
American and non-Hispanic White women, there was a lower 
consumption of fruits and vegetables among Mexican-American 
women with greater acculturation [22].  Furthermore, less 
acculturated Mexican-American participants had significantly 
higher servings of fruits and vegetables each day than Mexican-
Americans who were more acculturated to American customs 
[22].  This suggests that acculturation could be an independent 
predictor of diet.  It can also be suggested that the American 
culture does not support a diet high in fruits and vegetables and 
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that there is an association between level of acculturation and 
fruit and vegetable consumption among Hispanics. 
 
Another study reports that Hispanics, regardless of their level of 
acculturation, were significantly less likely than non-Hispanic 
Whites to prefer the “fruit and breakfast cereal” diet and more 
likely to prefer the “high starchy foods” diet [177]. Accordingly, 
the rice and starchy food diet, common among Hispanics, was 
associated with a significantly higher BMI and waist 
circumference when compared with the fruits and breakfast 
cereals diet [178]. 
 
Acculturation appears to also be positively associated with 
participating in leisure-time physical activity [178].  This may be 
due to the aforementioned neighborhood environment and 
socioeconomic status of Hispanics resulting in environmental and 
economic barriers to accessing fitness facilities, such as gyms, 
and safe recreational areas where they can participate in 
physical activities [178]. 
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Conclusion 
Several non-biological risk factors positively affect cardiovascular 
disease risk.  These factors are connected in such a way that one 
factor may have an effect on another factor which results in an 
increase in cardiovascular or metabolic disease risk.  Therefore, 
due to multiple risk factors and their interlinking tendencies, it is 
difficult to know which of the factors causes an increased risk for 
cardiovascular disease the most. 
 
Specific information among Mexican-Americans is scarce, and it 
is difficult to generalize the findings of prior studies to the 
Mexican-American population of the Phoenix metropolitan area 
due to differing environmental factors, known or unknown, which 
may have contributed to the results of prior studies.  Therefore, 
the purpose of this preliminary study is to conduct an initial 
assessment of the effects of non-biological factors on 
cardiometabolic risk among Mexican-Americans living in 
metropolitan Phoenix. 
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METHODS AND MATERIALS  
This study was approved by the Institutional Review Board at 
Arizona State University (IRB Protocol # 0910004426; PI: Sonia 
Vega-López).  The approval notice is attached in Appendix I. 
 
Materials 
Reagents for measuring total cholesterol, LDL cholesterol, HDL 
cholesterol, triglycerides, glucose and hsCRP as well as deionized 
water were purchased from Roche Diagnostics (Indianapolis, IN).  
The reagent for measuring insulin was purchased from Siemens 
Medical Solutions Diagnostics (Los Angeles, CA). 
 
Participants 
Seventy-five self reported Mexican-American adults were 
recruited free from diabetes and chronic diseases between the 
ages of 21 and 60.  Participants were excluded if they followed a 
specific diet regime (veganism, very low carbohydrate diet, etc.), 
or if they were participating in any other research study in which 
diet was assessed or manipulated. Further exclusion criteria 
included: 
- Inability to walk for exercise 
- History of difficult vein access 
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- Fear of needles or blood drawing, or adverse reactions to blood 
drawing (fainting) 
- Body weight less than 110 lb 
- Pregnancy or breastfeeding 
- Use of cholesterol lowering medications (cholestyramine, 
colestipol, niacin, HMG CoA reductase inhibitors, gemfibrozil, 
fenofibrate, clofibrate, thiazide diuretics, ezetimibe, probucol, 
colesevelam, ciprofibrate, diphenylhydantoin) 
- Heart disease 
- Diabetes 
- Renal disease 
- Liver disease or hepatitis 
- Cancer 
- Thyroid disease unless controlled with medication for at least 6 
months 
 
Recruitment and Consenting 
Participants were recruited from Maricopa County using flyers 
and advertisements placed in local community centers and local 
stores, Spanish language community newsletters and 
newspapers, through the Maricopa Insulin Resistance Initiative 
database, and through electronic distribution list (Appendix II).  
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Individuals interested in participation in the study had a phone 
interview in which a trained research assistant explained the 
details of the study and answered any questions the participant 
may have had.  The interview had a threefold purpose: first, to 
explain study purpose and procedures; second, to obtain verbal 
consent for screening to assess if the potential participant 
qualified for the study; and third, to verify eligibility via a short 
questionnaire including questions about exclusion criteria 
(Appendix III).  A study visit was scheduled for those 
participants who meet the inclusion criteria.  Participants were 
mailed a food frequency questionnaire (Appendix IV) to complete 
prior to their visit.  At the beginning of the study visit, time was 
allotted to answer questions participants may have had after 
which written informed consent was obtained.  Participants were 
assured that participation was voluntary and that they were able 
to discontinue at any point if they chose to.  The informed 
consent form is attached in Appendix V. 
 
Study Design 
This study had a cross-sectional design with one visit per 
participant unless the participant failed to fast prior to their visit 
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for at least 8 hours at which point another appointment was 
scheduled for a blood draw only.  Data regarding socioeconomic 
factors including education, income, and employment, and 
lifestyle factors such as diet were gathered using a survey 
(Appendix VI).  Anthropometrics gathered included height, 
weight, body fat percentage, waist circumference, and blood 
pressure.  Biomarkers examined were total cholesterol, LDL 
cholesterol, HDL cholesterol, triglycerides, hsCRP, fasting blood 
glucose, and insulin. 
 
Study Protocol 
On the day scheduled for their visit, participants arrived between 
7:30 – 9:30 am after fasting for 12 hours.  The study procedures 
were explained and participants were allowed to ask questions 
prior to consenting to participate in the study.  Once written 
consent was collected, the completed food frequency 
questionnaire was retrieved and anthropometric measurements 
were taken including their weight, height, percent body fat, and 
waist and hip circumferences.  After a 5 minute rest blood 
pressure was also taken.  These measurements were taken in 
triplicate and were recorded using an Anthropometrics 
Documentation Form (Appendix VII). Following the 
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measurements, a venous blood sample was collected for the 
measurement of fasting chronic disease risk factors.  Record of 
fasting status and the successful completion of blood withdrawal 
were kept using a Blood Draw Documentation Form (Appendix 
VIII). 
 
Thereafter, the survey designed to collect socio-demographic, 
dietary, socioeconomic, and acculturation information was 
administered by a trained bilingual research assistant for survey 
administration consistency.  All survey instruments were 
available in English and Spanish and were administered to study 
participants in their language of preference (Appendix VI). 
 
Methods 
Anthropometrics 
Weight was measured in kilograms using a Tanita body 
composition analyzer (Tanita Corporation, Tokyo, Japan) which 
also measured percent body fat.  Height was measured in 
centimeters using a wall mounted stadiometer.  Waist and hip 
circumferences were measured using a flexible tape measure.  
Waist was measured at the belly button, and hip was measured 
at the largest portion of the hips.  Blood pressure was taken 
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following a 5 minute rest from the participant’s left arm using an 
electronic sphygmomanometer (IntelliSense Blood Pressure 
Monitor HEM-907XL, Omron Healthcare, Kyoto City, Japan).  All 
measurements were taken in triplicate to ensure validity.  Body 
mass index (BMI) was calculated as mean weight in kilograms 
divided by mean height in meters squared (kg/m2). 
Biological Markers 
A 40 mL sample of fasting blood was drawn for the 
measurement of biological markers of CVD risk including 
glucose, insulin, hsCRP, and lipids (total cholesterol, HDL 
cholesterol, triglycerides).  Serum/plasma was separated by 
centrifugation at 1,100 x g at 4°C for 20 minutes.  Samples were 
aliquoted and frozen at -80 °C until analyzed.   
 
A complete lipid panel (total cholesterol, HDL cholesterol and 
triglycerides) and glucose were measured in serum with 
colorimetric enzymatic assays using an automated chemistry 
analyzer (Cobas C111; Roche Diagnostics, Indianapolis, IN). LDL 
cholesterol was calculated using the Friedewald equation [179].  
Homeostatic model assessment (HOMA) is a method used in 
order to compare insulin resistance and beta-cell function.  It 
61 
 
was calculated as: fasting plasma glucose (mM) x insulin 
(µU/ml)/22.5 [180, 181]. 
 
Serum hsCRP was measured with a turbidimetric assay using an 
automated chemistry analyzer (Cobas C111; Roche Diagnostics, 
Indianapolis, IN).  The automated chemistry analyzer was 
calibrated and tested for quality control for each analysis.  
Insulin was measured by immunoassay using an automated 
instrument (Immulite, Siemens Medical Solutions Diagnostics, 
Los Angeles, CA).   
 
Diet Analysis 
Diets were assessed using the semi-quantitative Southwestern 
Food Frequency Questionnaire (Appendix IV) [182, 183].  This 
food frequency questionnaire was chosen because it is a bilingual 
questionnaire widely used in the United States and includes 
foods that are culturally appropriate for the Mexican diet.  
Information derived from this questionnaire focused on dietary 
macronutrient composition, namely total fat, saturated fat, trans 
fat, complex carbohydrates, and protein.  Data was also 
analyzed to reflect the percent of energy in kilocalories that 
came from total fat, saturated fat, trans fat, monounsaturated 
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fatty acids (MUFA), polyunsaturated fatty acids (PUFA), 
carbohydrates, and protein. 
 
Socioeconomic Factors 
Participants completed a survey that included questions 
regarding last level of education completed, monthly total 
household income, acculturation, and employment status 
(Appendix VI).  Acculturation was measured using the 
Acculturation Rating Scale for Mexican-Americans – II (ARSMA-
II; Appendix IX) [184], a multidimensional scale designed to 
measure acculturation related to language, ethnic identity, and 
ethnic interaction. The factor structure, reliability, and validity of 
the ARSMA-II have been well established in English and Spanish 
[184]. 
 
The acculturation part of the survey included questions that 
asked the participant about certain daily activities (e.g. 
speaking, reading, watching TV, listening to music, friends, etc.) 
done in either English or Spanish.  The participant responded 
with how often they did the certain activity in either English or 
Spanish.  The questions are classified as either an Anglo 
Orientation Scale (AOS) or Mexican Orientation Scale (MOS).  
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Each participant is scored (1-5) according to their answers to the 
AOS and MOS questions. 
 
The mean score for the MOS questions is subtracted from the 
mean score for the AOS questions in order to obtain an 
acculturation score.  A scale is then used to determine, from the 
participant’s acculturation score, what their acculturation 
level/categorization is.  An acculturation level of 1 is a person 
who is very Mexican oriented with an acculturation score of <-
1.33.  An acculturation level of 2 means the person is between 
being Mexican oriented and being approximately balanced 
biculturally.  Level 2 includes acculturation scores ≥-1.33 to ≤-
0.07.  Level 3 are those Mexicans with a slightly Anglo oriented 
biculture and a score between >-0.07 and <1.19.  Level 4 
includes scores of ≥1.19 and <2.45 and defines Mexicans as 
being strongly Anglo oriented.  Lastly, Level 5 are those 
Mexicans who are very assimilated and anglicized with a score 
≥2.45 (Appendix IX). 
 
Data Analysis and Interpretation 
Statistical analyses were conducted using SPSS 17.0 for 
Windows (SPSS, Inc., Chicago, IL).  Data was examined for 
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normality and, if necessary, was transformed.  The biological 
data that was transformed includes triglycerides (inverse), 
hsCRP (log), and insulin (log).  The only data from macronutrient 
consumption that was transformed was total energy (log).  
Correlation analyses were used to explore the relation among 
acculturation, diet macronutrient composition, and 
anthropometric measurements with cardiometabolic risk factors.  
In addition to descriptive tables and plots, explanatory variables 
were tested using analysis of variance (ANOVA).  ANOVA 
stratified participants based on income, employment, education, 
and acculturation categories.  The post-hoc LSD was used for 
analyzing biological markers and macronutrient consumption 
with income, education, and acculturation. 
 
Outliers were defined as data that was more than 3 standard 
deviations from the mean.  Biological data containing outliers 
that were removed for the statistical analysis included: BMI, 
diastolic blood pressure, total cholesterol, LDL cholesterol, 
LDL/HDL cholesterol ratio, total/HDL cholesterol ratio, 
triglycerides, high sensitivity C-reactive protein (hsCRP), and 
fasting plasma glucose.  One participant had an extremely 
elevated triglyceride concentration which made it impossible to 
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calculate the LDL cholesterol and the LDL/HDL cholesterol ratio 
using the Friedewald calculation.  The macronutrient data 
containing outliers that were removed included: total energy, 
total fat, saturated fat, trans fat, carbohydrates, sugar, and 
protein. 
 
66 
 
RESULTS 
Participant Sociodemographic Characteristics 
A total of 75 individuals participated in this study.  A majority of 
the participants were female (n= 49, 65.3% female; n=26, 
34.7% male).  All of the participants self identified themselves 
as Mexican (n=37, 49%), Mexican-American (n=28, 37%), or 
Hispanic/Latino (n=10, 13%).  The mean residence time in the 
United States was 23.8 years (SD=±14.8) [Table 1].   
 
The level of education that was completed by the participants 
are as follows: 5% completed elementary school, 15% 
completed middle school, 15% completed high school, 36% 
completed some college, and 29% were college graduates or 
higher.  Sixty-seven percent (n=50) of the participants spoke 
both Spanish and English, 25% (n=19) of the participants spoke 
Spanish only, and 8% (n=6) spoke English only [Table 1]. 
 
Sixty-one percent (n=45) of the participants were employed at 
the time of the study.  Of those, 35 participants (47% of total) 
were working full time (≥35 hrs/week) and 10 participants (14% 
of total) were working part time (<35 hrs/week).  Thirty-nine 
percent (n=29) of the participants were not employed.   
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Seventeen participants (23%) had a household monthly income 
of $0-1000, 18 participants (24%) had a household monthly 
income of $1001-2000, 15 participants (20%) had a household 
monthly income of $2001-3000, 9 participants (13%) had a 
household monthly income of $3001-4000, and 15 participants 
(20%) had a household monthly income of >$4000 [Table 1]. 
 
Acculturation level was ranked based on their calculated 
acculturation score on a scale from 1 to 5 (ARSMA-II) [184].  
Those with an acculturation level of 1 are least acculturated to 
the American culture, and those with an acculturation score of 5 
are most acculturated to the American culture.  The mean 
acculturation level for the participants was 2.27±1.11.  The 
majority of participants had an acculturation level of 1 (n=25, 
34%).  Fifteen participants (21%) had an acculturation level of 
2, and 21 participants (29%) had an acculturation level of 3.  
The least number of participants had an acculturation level of 4 
(n=12, 16%).  Two participants had incomplete data which 
prevented the calculation of their acculturation level.  Therefore, 
they were not included in this data [Table 1]. 
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Participants were classified according to the Mexican-American 
generation they belong to as follows: 1st generation=born in 
Mexico or other country; 2nd generation=born in the US, at least 
one parent born in Mexico or other country; 3rd generation=born 
in the US, both parents born in the US, all grandparents born in 
Mexico or other country; 4th generation=born in the US, both 
parents born in the US, at least one grandparent born in Mexico 
or other country; 5th generation=born in US, both parents born 
in US, all grandparents born in US.  Fifty-three percent of the 
participants were 1st generation (n=40), 28% of the participants 
were 2nd generation (n=21), the rest were 3rd, 4th, or 5th 
generation (n=1, 1%; n=9, 12%, n=4, 5%, respectively) [Table 
1]. 
 
Cardiometabolic disease risk factors 
The cardiometabolic disease risk factors for the male and female 
participants were compared using an independent sample t-test 
[Table 2].  One participant had an extremely elevated 
triglyceride level which made it impossible to calculate LDL using 
the Friedewald equation.  Thus, the ratio between cholesterol in 
LDL and HDL also could not be calculated for that participant. 
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The mean participant age was 37.6±9.3 years.  Mean weight 
was 78±16 kg.  Mean BMI was 28.9±5.3 kg/m2.  Male 
participants had 15% greater weight than female participants 
(85±13 kg vs. 74±16 kg, p=0.005), but BMI did not significantly 
differ between males and females.  Mean waist circumference 
was 95±13 cm.  Mean percent body fat was 34±9.1 and was 
40% greater in females than males (37.7±8.7% vs. 26.9±4.8%, 
p<0.0001).  Mean systolic blood pressure was 117±11 mm Hg 
and mean diastolic blood pressure was 73±9 mm Hg, with no 
differences between male and female participants.  Mean total, 
LDL-, and HDL-cholesterol concentrations were 183±39 mg/dL, 
114±32 mg/dL, and 44±11 mg/dL, respectively.  HDL 
cholesterol was 24% higher in females than in males (47±11 
mg/dL vs. 38±11 mg/dL, p=0.001).  Mean total/HDL cholesterol 
ratio was 4.5±2.0.  Male participants had 38% higher total/HDL 
cholesterol ratio than female participants (5.5±2.7 vs. 4.0±1.2, 
p=0.015).  Mean LDL/HDL cholesterol ratio was 2.8±1.1 and was 
32% higher for males than females (3.3±1.2 vs. 2.5±0.9, 
p=0.002).  Mean triglycerides were 115±61 mg/dL and mean 
hsCRP was 4.2±6.7 mg/L.  Mean fasting plasma glucose was 
94±14 mg/dL, and male participants had 9% higher glucose 
concentrations than female participants (99±21 mg/dL vs. 91±7 
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mg/dL, p=0.018).  Mean insulin was 8.7±5.8 µIU/mL.  Mean 
HOMA score was 2.0±1.4. 
 
Association of cardiometabolic disease risk factors with 
non-biological factors 
Cardiometabolic disease risk factors after stratifying participants 
based on non-biological factors (income, education, 
employment, acculturation level) are displayed in Tables 3-6.  
When stratifying participants based on income [Table 3], those 
with a household income between $2001 and $3000 per month 
had 20% greater waist circumference than those participants 
with a household monthly income between $3001 and $4000 
(103±11 cm vs. 86±11 cm, p=0.017). Similarly, weight and BMI  
were significantly higher among participants with a monthly 
income of $2001-3000 relative to those earning $3001-4000 per 
month (89±15 kg vs. 65±13 kg, p=0.037; 31.4±3.6 kg/m2 vs. 
25.6±3.9 kg/m2, p=0.005; respectively).  The rest of the 
cardiometabolic disease risk factors did not differ by income level 
[Table 3]. 
 
Participants were stratified into income categories of those who 
earn ≤$3000 per month and those who earn >$3000 per month.  
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Those earning ≤$3000 per month had significantly higher 
weight, BMI, and waist circumferences than those earning 
>$3000 per month (81±15 kg vs. 71±15 kg, p=0.005; 
29.8±4.6 kg/m2 vs. 26.5±5.1 kg/m2, p=0.007; 98±12 cm vs. 
89±14 cm, p=0.008; respectively).  Furthermore, HDL 
cholesterol concentrations were significantly higher for those 
earning>$3000 than those earning ≤$3000 per month (49±12 
mg/dL vs. 41±10 mg/dL, p=0.003).  When compared to those 
earning >$3000 per month, glucose, insulin, and HOMA were 
significantly higher than those earning ≤$3000 per month (93±7 
mg/dL vs. 90±5 mg/dL, p=0.048; 9.7±5.9 µIU/mL vs. 6.4±51 
µIU/mL, p=0.023; 2.2±1.4 vs. 1.5±1.2, p=0.019; respectively) 
[Table 4]. 
 
After stratifying participants according to education, weight was 
significantly higher for those who completed elementary school 
or those who completed high school than for those who 
completed some college (93±19 kg, 87±17, and 72±14 kg, 
respectively; p=0.023). HDL cholesterol was significantly higher 
in participants who had completed some college or graduated 
from college than those who completed elementary school 
(47±10 mg/dL & 47±12 mg/dL vs. 33±10 mg/dL, p=0.005; 
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respectively). Similarly, the total/HDL cholesterol ratio was 
significantly higher for participants who completed elementary 
school when compared with all other levels of education 
(Elementary, 6.7±1.3 vs. Middle School, 5.0±1.3; High School, 
4.9±0.8; Some College, 3.6±0.9; College Graduate 4.3±1.5; 
p<0.0001). The LDL/HDL cholesterol ratio was significantly lower 
for participants who had completed some college or graduated 
from college than those who completed elementary school 
(2.2±0.8 & 2.7±1.1 vs. 3.9±1.1, respectively; p=0.002). 
Triglycerides were significantly higher for participants who 
completed elementary school than for those who completed high 
school, some college, or graduated from college (195±68 mg/dL 
vs. 115±40 mg/dL, 89±32 mg/dL, and 116±70 mg/dL, 
respectively; p=0.005) [Table 5]. 
 
The cardiometabolic disease risk factors were also compared 
among participants when education was also grouped into three 
categories: (1) those that completed elementary, middle, and 
high school, (2) those that completed some college, and (3) 
those who were college graduates or higher [Table 6].  
Compared to those who completed some college, those who 
completed elementary, middle, and high school had a 
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significantly higher weight (84±16 kg vs. 72±14 kg, p=0.024), 
significantly higher BMI (30.6±4.2 kg/m2 vs. 26.9±4.9 kg/m2, 
p=0.024), and significantly larger waist circumference (100±11 
cm vs. 91±13 cm, p=0.029).  Participants who completed only 
elementary, middle or high school had significantly lower HDL 
cholesterol concentrations (37±9 mg/dL vs. 47±10 mg/dL & 
47±12 mg/dL, respectively; p=0.001).  Compared to those who 
completed some college and those who were college graduates 
or higher, those who completed elementary, middle, and high 
school had a significantly higher total/HDL cholesterol ratio 
(5.2±1.2 vs. 3.6±1.9 & 4.3±1.5, respectively; p<0.0001) and 
significantly higher LDL/HDL cholesterol ratio (3.3±0.8 vs. 
2.2±0.8 & 2.7±1.1, respectively; p=0.001).  Participants who 
completed elementary, middle, and high school had the highest 
triglycerides concentrations (138±67 mg/dL vs. 89±32 mg/dL & 
116±70 mg/dL, respectively; p=0.011) and fasting plasma 
glucose (94±7 mg/dL vs. 92±7 mg/dL & 89±5 mg/dL, 
respectively; p=0.030) [Table 6].  There were no other 
significant differences between the groups. 
 
When comparing participants based on employment status, 
those who were employed had 15% greater HDL cholesterol 
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concentrations than participants not employed (46±10 mg/dL 
vs. 40±12 mg/dL, p=0.024) [Table 7].  Among participants who 
were working, cardiometabolic disease risk factors were not 
significantly different when comparing those employed full time 
vs. those employed part time [Table 7].  Despite the lack of 
significance, HDL cholesterol was 20% higher in full-time 
employees relative to part-time workers (48±10 mg/dL vs. 40±9 
mg/dL; p=0.051). 
 
There were no significant differences in cardiometabolic disease 
risk factors when stratifying participants based on their 
acculturation level [Table 8]. 
 
Dietary Macronutrients 
Participants’ daily macronutrient composition of the diet is 
displayed in Table 9.  Mean participant energy consumption was 
2447±1371 kcal.  Men consumed 20% more energy than women 
(2761±1542 kcal vs. 2293±1267 kcal), but this difference did 
not reach statistical significance (p=0.172).  Mean total fat 
consumption was 89±56 grams.  Male participants consumed 
37% more grams of total fat than female participants (108±66 
g/d vs. 79±48 g/d, p=0.037).  Mean saturated fatty acid intake 
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was 30±19 grams. The mean consumption of trans fatty acid 
was 1.5±1.2 grams.  Mean participant carbohydrate 
consumption was 345±224 grams of which 44% (151±126 g) 
corresponded to sugar.  Mean daily protein intake was 109±70 
grams, with men consuming 40% more protein than women 
(134±89 g vs. 96±54 g; p=0.056).  The contribution of 
macronutrients towards energy intake is as follows: 31±5% of 
energy from total fat, 53±7% from carbohydrates, and 17±3% 
from protein, with no significant differences in macronutrient 
composition of the diet between men and women despite the 
difference in total fat intake noted above. Participants consumed 
10.3±2.2% of energy, 12.1±1.9% of energy, and 6.1±1.2% of 
energy from saturated, monounsaturated, and polyunsaturated 
fatty acids, respectively.  Of the 53% of energy consumed from 
carbohydrates, almost half (23±6% of total energy) was 
consumed as sugar [Table 9]. 
 
Macronutrient consumption and non-biological factors 
The dietary macronutrient composition after stratifying 
participants based on non-biological factors (income, education, 
employment, acculturation level) are displayed in Tables 10-15.  
When stratifying participants based on income, those earning 
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between $2001 and $3000 per month had a significantly greater 
intake of trans fatty acids (2.1±1.5 g/d) than participants in the 
other subgroups (p=0.047). Participants in this subgroup 
consumed 110% more trans fatty acids than participants in the 
income bracket of $0-1000, 62% more than those with an 
income of $1001-2000, 75% more than those with an income of 
$3001-4000, and 50% more than those with an income of 
>$4000 (1.0±0.6 g/d, 1.3±0.9 g/d, 1.2±0.8 g/d, and 1.4±1.0 
g/d, respectively; p=0.047) [Table 10].  There were no other 
macronutrient intake differences when stratifying participants by 
income. 
 
After stratifying participants according to income (≤$3000 or 
>$3000 per month) [Table 11], percent of energy from total fat 
and from monounsaturated fatty acids was significantly higher 
for those earning ≤$3000 than for those earning >$3000 per 
month (32±5% vs. 29±3%, p=0.042; 12.4±2.1% vs. 
11.4±1.4%, p=0.031; respectively).  Participants with an 
income of >$3000 per month had a higher consumption of 
energy from carbohydrates than those with an income ≤$3000 
per month (56±4% vs. 52±8%, p=0.027) [Table 11].  
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When stratifying participants based on education level, the only 
significant differences detected were related to percent of energy 
from polyunsaturated fatty acids.  Participants with some college 
education consumed 40% more energy from polyunsaturated 
fatty acids relative to those who completed high school 
(6.5±1.1% energy vs. 5.1±0.8% energy, p=0.007) [Table 12]. 
 
Macronutrient consumption was also compared among 
participants when education was also grouped into three 
categories: (1) those who completed elementary, middle, and 
high school, (2) those who completed some college, and (3) 
those who were college graduates or higher.  These groups were 
compared according to macronutrient consumption of the 
participants.  The only significant difference was that those who 
completed some college consumed a significantly higher 
percentage of energy from polyunsaturated fatty acids than 
those who completed elementary, middle, and high school 
(6.5±1.1% vs. 5.6±1.0%, p=0.010) [Table 13].   
 
Diet data based on employment status was analyzed using an 
independent samples t-test.  Employed individuals consumed 
27% less grams of polyunsaturated fatty acids than unemployed 
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individuals (14.5±7.4 g vs. 19.8±12.6 g, p=0.049).  Relative to 
employed participants, unemployed individuals had a 12% 
significantly greater energy intake from saturated fatty acids 
(11.0±2.6% energy vs. 9.8±1.8% energy, p=0.023).  No 
significant differences were found between macronutrient 
consumption and full- or part-time employment status [Table 
14]. 
 
No significant differences in macronutrient consumption were 
observed when stratifying participants based on acculturation 
category [Table 15]. 
 
Cardiometabolic disease risk factors and macronutrient 
consumption 
The associations between cardiometabolic disease risk factors 
and macronutrient consumption were analyzed using Pearson 
and Spearman correlations.  This data is displayed in Table 16.  
Weight was positively correlated with percent energy from total 
fat (r=0.330, p=0.004), percent energy from monounsaturated 
fatty acids (r=0.412, p=0.000), and percent energy from 
polyunsaturated fatty acids (r=0.241, 0.037), and was 
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negatively correlated with percent energy from carbohydrates 
(r=-0.311, p=0.007). 
 
BMI was positively correlated with percent energy from total fat 
(r=0.231, p=0.048), and percent energy from monounsaturated 
fatty acid (r=0.293, p=0.011) [Table 16].  Waist circumference 
was positively associated with almost all of the macronutrients 
including percent energy from total fat (r=0.300, p=0.009), 
percent energy from trans fatty acid (r=0.242, p=0.037), 
percent energy from monounsaturated fatty acid (r=0.396, 
p=0.000), and percent energy from polyunsaturated fatty acid 
(r=0.239, p=0.039).  Waist circumference was also negatively 
associated with percent energy from carbohydrates (r=-0.248, 
p=0.032). 
 
There was a positive correlation between percent energy from 
monounsaturated fatty acids and systolic (r=0.247, p=0.033) 
and diastolic (r=0.261, p=0.025) blood pressure [Table 16].  
There was a positive correlation between hsCRP and percent 
energy from monounsaturated fatty acid (r=0.244, p=0.036).  
Insulin was positively correlated with percent of energy from 
total fat (r=0.258, p=0.026), percent energy from trans fatty 
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acid (r=0.311, p=0.007), and percent of energy from 
monounsaturated fatty acids (r=0.238, p=0.040).  HOMA was 
positively correlated with percent energy from trans fatty acid 
(r=0.254, p=0.030) [Table 16]. 
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Table 1. Sociodemographic characteristics of study participants 
 
Characteristics n 
Percent 
of Total 
Mean ± 
SD 
 
Characteristics n 
Percent 
of Total 
Gender 75   
 
Employment 741  
Male 26 34.7 - 
 
Employed 45 60.8 
Female 49 65.3 - 
 
Full-Time 35 47.3 
Age 75 - 37.6±9.3 
 
Part-Time 10 13.5 
Self 
Identification 
75 
 
 
 
Not Employed 29 39.2 
Mexican 37 49.3 - 
 
Language Spoken 75  
Mexican-
American 
28 37.3 - 
 
Spanish 19 25.3 
Hispanic/ 
Latino 
10 13.3 - 
 
English 6 8.0 
Time in the US 
(years) 
75 - 
23.8± 14.8 
(1-56) 
 
Both 50 66.7 
Education 
(Completed) 
75 
 
 
 
Acculturation Level 731  
Elementary 4 5.3 - 
 
1-Mexican 25 34.2 
Middle 
School 
11 14.7 - 
 
2 15 20.5 
High School 11 14.7 - 
 
3 21 28.8 
Some College 27 36.0 - 
 
4 12 16.4 
College 
Graduate or 
Higher 
22 29.3 - 
 
5-Anglo 0 0.0 
Monthly Income 741   
 
Generation 75  
$0-1000 17 23.0 - 
 
1st 40 53.3 
$1001-2000 18 24.3 - 
 
2nd 21 28.0 
$2001-3000 15 20.3 - 
 
3rd 1 1.3 
$3001-4000 9 12.2 - 
 
4th 9 12.0 
>$4000 15 20.3 - 
 
5th 4 5.3 
1 - Unable to show representation of total sample due to incomplete data. 
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Table 2. Cardiometabolic disease risk factors of study 
participants1 
Characteristics 
All  
(n=75) 
 Men 
(n=26) 
Women 
(n=49) 
p 
value2 
Age (years) 37.6±9.3 
 
39.5±1.6 36.6±1.4 0.179 
Weight (kg) 78±16 
 
85±13 74±16 0.005 
BMI (kg/m2) 28.9±5.3 
 
28.9±3.5 28.9±6.1 0.945 
Waist Circumference (cm) 95±13 
 
98±10 93±14 0.061 
Percent Body Fat (%) 34.0±9.1 
 
26.9±4.8 37.7±8.7 0.000 
Systolic Blood Pressure  
(mm Hg) 
117±11 
 
120±10 115±12 0.050 
Diastolic Blood Pressure  
(mm Hg) 
73±9 
 
76±9 72±9 0.148 
Total Cholesterol (mg/dL) 183±39 
 
189±51 179±30 0.390 
HDL Cholesterol (mg/dL) 44±11 
 
38±11 47±11 0.001 
LDL Cholesterol (mg/dL) 3 114±32 
 
121±42 111±25 0.253 
Total/HDL Cholesterol Ratio 4.5±2.0 
 
5.5±2.7 4.0±1.2 0.015 
LDL/HDL Cholesterol Ratio 3 2.8±1.1 
 
3.3±1.2 2.5±0.9 0.002 
Triglycerides (mg/dL) 3 115±61 
 
123±68 110±57 0.378 
hsCRP (mg/L) 4.2±6.7 
 
4.3±10.3 4.2±3.9 0.940 
Fasting Plasma Glucose 
(mg/dL) 
94±14 
 
99±21 91±7 0.018 
Insulin (µIU/mL) 8.7±5.8 
 
8.0±4.9 9.1±6.3 0.449 
HOMA 2.0±1.4 
 
1.9±1.1 2.1±1.5 0.633 
1 - Data displayed as mean ± SD. 
2 - Mean values for women and men were compared using an independent samples t-test. 
3 - n=74; one participant excluded due to extremely high triglyceride levels. Unable to 
calculate LDL Cholesterol and LDL/HDL Cholesterol Ratio. 
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Table 3. Cardiometabolic disease risk factors stratified by 
income1 
 
$0-1000 
(n=17) 
$1001-
2000 
(n=18) 
$2001-
3000 
(n=15) 
$3001-
4000 
(n=9) 
>$4000 
(n=15) 
p-
value2 
Weight (kg) 
80±16ab 
(60-120) 
77±14bc 
(53-95) 
89±15a 
(69-127) 
65±13c 
(50-86) 
74±16bc 
(52-102) 
0.005 
BMI (kg/m2) 3 
29.7±4.7ab 
(21.4-37.0) 
28.7±5.1abc 
(20.5-38.7) 
31.4±3.6a 
(26.7-38.5) 
25.6±3.9c 
(21.2-30.5) 
27.1±5.8bc 
(19.9-38.8) 
0.037 
Waist 
Circumference 
(cm) 
97±11ab 
(82-117) 
94±12abc 
(67-113) 
103±11a 
(86-124) 
86±11c 
(71-107) 
92±13bc 
(73-130) 
0.017 
Percent Body 
Fat (%) 
34±9 
(19-49) 
33±10 
(18-47) 
36±9 
(24-53) 
32±7 
(24-43) 
35±10 
(21-49) 
0.866 
Systolic Blood 
Pressure  
(mm Hg) 
114±10 
(98-133) 
118±11 
(100-137) 
119±11 
(102-136) 
113±14 
(87-134) 
119±13 
(100-138) 
0.539 
Diastolic Blood 
Pressure  
(mm Hg) 3 
72±9 
(61-89) 
75±9 
(56-95) 
75±8 
(60-90) 
72±10 
(44-86) 
75±9 
(64-96) 
0.808 
Total 
Cholesterol 
(mg/dL) 3 
181±47 
(104-274) 
175±32 
(117-249) 
183±40 
(115-250) 
171±32 
(133-237) 
192±30 
(153-243) 
0.661 
HDL Cholesterol 
(mg/dL) 
39±9 
(20-55) 
42±12 
(18-70) 
41±8 
(28-54) 
48±14 
(21-71) 
50±12 
(31-67) 
0.054 
LDL Cholesterol 
(mg/dL) 3 
109±31 
(50-163) 
108±27 
(56-174) 
120±36 
(62-188) 
105±29 
(67-158) 
119±28 
(79-161) 
0.609 
Total/HDL 
Cholesterol 
Ratio 3 
4.8±1.3 
(2.7-7.2) 
4.3±1.3 
(2.5-7.1) 
4.5±1.2 
(3.1-6.9) 
4.0±1.8 
(2.4-8.2) 
4.2±1.5 
(2.5-7.8) 
0.562 
LDL/HDL 
Cholesterol 
Ratio 3 
3.1±1.1 
(1.3-5.2) 
2.6±0.9 
(1.2-4.4) 
3.0±0.9 
(1.7-4.6) 
2.1±0.8 
(1.3-3.3) 
2.6±1.1 
(1.3-5.2) 
0.131 
Triglycerides 
(mg/dL) 3 
131±69 
(50-266) 
117±69 
(54-273) 
105±50 
(40-195) 
91±36 
(43-139) 
118±67 
(53-259) 
0.554 
hsCRP (mg/L) 3 
3.5±3.9 
(0.2-13.9) 
2.5±2.1 
(0.3-6.9) 
4.7±4.3 
(0.2-14.1) 
2.0±2.0 
(0.1-5.7) 
3.0±2.7 
(0.2-8.1) 
0.287 
Fasting Plasma 
Glucose 
(mg/dL) 3 
95±6 
(85-107) 
94±8 
(81-109) 
90±6 
(80-103) 
88±4 
(82-95) 
91±6 
(81-101) 
0.054 
Insulin 
(µIU/mL) 
10.6±7.0 
(3.6-25.1) 
8.9±5.4 
(2.0-25.3) 
9.8±5.3 
(2.0-16.9) 
6.0±4.5 
(2.0-15.5) 
6.7±5.5 
(2.0-22.6) 
0.203 
HOMA 
2.6±1.6 
(0.8-5.9) 
2.0±1.2 
(0.5-5.5) 
2.2±1.2 
(0.5-3.8) 
1.3±1.0 
(0.4-3.4) 
1.5±1.3 
(0.4-5.5) 
0.137 
1 - Data displayed as Mean ± SD (Range).  Mean values with different superscripts are 
significantly different 
2 - Mean values were compared using an ANOVA test with LSD post-hoc 
3 - Data more than 3 SD from the mean were excluded 
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Table 4. Cardiometabolic disease risk 
factors stratified by income category1 
 ≤$3000 
(n=50) 
>$3000 
(n=24)2 
p-value3 
Weight (kg) 
81±15 
(53-127) 
71±15 
(50-102) 
0.005 
BMI (kg/m2) 4 
29.8±4.6 
(20.5-38.7) 
26.5±5.1 
(19.9-38.8) 
0.007 
Waist 
Circumference 
(cm) 
98±12 
(67-124) 
89±14 
(71-130) 
0.008 
Percent Body Fat 
(%) 
34.1±9.4 
(18.1-53.3) 
33.5±8.9 
(21.1-48.9) 
0.789 
Systolic Blood 
Pressure  
(mm Hg) 
117±10 
(98-137) 
117±13 
(87-138) 
0.929 
Diastolic Blood 
Pressure  
(mm Hg) 4 
74±9 
(56-95) 
73±9 
(57-96) 
0.771 
Total Cholesterol 
(mg/dL) 4 
179±39 
(104-274) 
183±31 
(133-243) 
0.629 
HDL Cholesterol 
(mg/dL) 
41±10 
(18-70) 
49±12 
(21-71) 
0.003 
LDL Cholesterol 
(mg/dL) 4 
112±31 
(50-188) 
113±28 
(67-161) 
0.907 
Total/HDL 
Cholesterol Ratio 4 
4.5±1.3 
(2.5-7.2) 
4.1±1.6 
(2.4-8.2) 
0.199 
LDL/HDL 
Cholesterol Ratio 4 
2.9±1.0 
(1.2-5.2) 
2.4±1.0 
(1.3-5.2) 
0.057 
Triglycerides 
(mg/dL) 4 
118±63 
(40-273) 
108±58 
(43-259) 
0.488 
hsCRP (mg/L) 4 
3.5±3.5 
(0.2-14.1) 
2.7±2.4 
(0.1-8.1) 
0.300 
Fasting Plasma 
Glucose (mg/dL) 4 
93±7 
(80-109) 
90±5 
(81-101) 
0.048 
Insulin (µIU/mL) 
9.7±5.9 
(2.0-25.3) 
6.4±5.1 
(2.0-22.6) 
0.023 
HOMA 
2.2±1.4 
(0.5-5.9) 
1.5±1.2 
(0.4-5.5) 
0.019 
1 - Data displayed as Mean ± SD (Range).   
2 - Data for one participant not available 
3 - Mean values for income categories were compared using 
an independent samples t-test 
4 - Data more than 3 SD from the mean were excluded 
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Table 5. Cardiometabolic disease risk factors stratified by level of 
education1 
 Completed 
Elementary 
School 
(n=4) 
Completed 
Middle 
School 
(n=11) 
Completed 
High 
School 
(n=11) 
Some 
College 
(n=27) 
College 
Grad or 
Higher 
(n=22) 
p-
value
2
 
Weight (kg) 
93±19a 
(75-120) 
77±11ab 
(57-99) 
87±17a 
(70-127) 
72±14b 
(50-93) 
76±17ab 
(53-106) 
0.023 
BMI (kg/m2) 3 
32.2±3.3 
(29.4-36.8) 
29.8±4.6 
(23.0-38.5) 
30.9±4.2 
(24.3-38.7) 
26.9±4.9 
(19.9-38.8) 
28.6±5.2 
(20.2-37.0) 
0.087 
Waist 
Circumference 
(cm) 
104±12 
(87-117) 
96±10 
(81-110) 
102±12 
(85-124) 
91±13 
(67-130) 
95±13 
(73-117) 
0.071 
Percent Body 
Fat (%) 
34.7±6.3 
(29.0-42.5) 
34.3±8.8 
(22.0-50.4) 
36.2±11.3 
(19.4-53.3) 
32.1±8.8 
(18.1-48.9) 
34.8±9.3 
(21.1-48.5) 
0.739 
Systolic Blood 
Pressure  
(mm Hg) 
122±13 
(104-133) 
113±10 
(98-127) 
115±9 
(106-136) 
119±15 
(87-138) 
116±8 
(103-133) 
0.521 
Diastolic Blood 
Pressure  
(mm Hg) 3 
75±9 
(63-82) 
70±9 
(60-86) 
76±7 
(66-89) 
76±10 
(56-96) 
72±7 
(57-84) 
0.303 
Total 
Cholesterol 
(mg/dL) 3 
210±40 
(176-262) 
195±30 
(153-248) 
170±41 
(105-274) 
171±36 
(104-249) 
187±33 
(128-250) 
0.095 
HDL Cholesterol 
(mg/dL) 
33±10b 
(21-46) 
41±10ab 
(28-58) 
36±8b 
(20-44) 
47±10a 
(18-67) 
47±12a 
(30-71) 
0.005 
LDL Cholesterol 
(mg/dL) 3 
138±28 
(102-163) 
126±27 
(93-184) 
101±19 
(62-136) 
105±32 
(50-174) 
117±29 
(67-188) 
0.065 
Total/HDL 
Cholesterol 
Ratio 3 
6.7±1.3a 
(5.6-8.2) 
5.0±1.3b 
(3.5-6.9) 
4.9±0.8b 
(3.8-6.3) 
3.6±0.9c 
(2.4-6.3) 
4.3±1.5bc 
(2.5-7.8) 
0.000 
LDL/HDL 
Cholesterol 
Ratio 3 
3.9±1.1a 
(3.1-5.2) 
3.2±0.8ab 
(2.2-4.5) 
3.2±0.7ab 
(2.4-4.9) 
2.2±0.8c 
(1.2-4.4) 
2.7±1.1bc 
(1.3-5.2) 
0.002 
Triglycerides 
(mg/dL) 3 
195±68a 
(119-266) 
142±80ab 
(50-258) 
115±40bc 
(47-167) 
89±32c 
(48-178) 
116±70bc 
(40-273) 
0.005 
hsCRP (mg/L) 3 
3.7±4.4 
(0.2-9.7) 
4.7±4.3 
(0.5-13.9) 
2.7±2.0 
(0.2-6.8) 
3.0±3.3 
(0.1-14.1) 
2.9±2.8 
(0.2-10.3) 
0.594 
Fasting Plasma 
Glucose 
(mg/dL) 3 
95±6 
(86-101) 
95±9 
(80-107) 
93±6 
(85-104) 
92±7 
(82-109) 
89±5 
(81-98) 
0.107 
Insulin 
(µIU/mL) 
12.8±7.2 
(6.1-22.4) 
8.7±6.4 
(2.0-24.7) 
11.3±7.9 
(3.7-25.3) 
8.4±5.3 
(2.0-22.6) 
7.2±4.4 
(2.0-16.7) 
0.215 
HOMA 
2.9±1.5 
(1.5-4.8) 
2.0±1.6 
(0.5-5.7) 
2.8±1.8 
(0.8-5.9) 
1.9±1.3 
(0.4-5.5) 
1.6±1.0 
(0.4-3.5) 
0.137 
1 - Data displayed as Mean ± SD (Range).  Mean values with different superscripts are 
significantly different 
2 - Mean values were compared using an ANOVA test with LSD post-hoc 
3 - Data more than 3 SD from the mean were excluded 
 
86 
 
Table 6. Cardiometabolic disease risk factors stratified by 
completion of high school1 
 Completed 
Elementary, 
Middle, or 
High School 
(n=26) 
Some 
College 
(n=27) 
College 
Graduate 
or Higher 
(n=22) 
p-
value2 
Weight (kg) 
84±16a 
(57-127) 
72±14b 
(50-93) 
78±17ab 
(53-106) 
0.024 
BMI (kg/m2) 3 
30.6±4.2a 
(23.0-38.7) 
26.9±4.9b 
(19.9-38.8) 
28.6±5.2ab 
(20.2-37.0) 
0.024 
Waist 
Circumference 
(cm) 
100±11a 
(81-124) 
91±13b 
(67-130) 
95±13ab 
(73-117) 
0.029 
Percent Body Fat 
(%) 
35.2±9.3 
(19.4-53.3) 
32.1±8.8 
(18.1-48.9) 
34.8±9.3 
(21.1-48.5) 
0.413 
Systolic Blood 
Pressure  
(mm Hg) 
115±10 
(98-136) 
119±15 
(87-138) 
116±8 
(103-133) 
0.503 
Diastolic Blood 
Pressure  
(mm Hg) 3 
73±8 
(60-89) 
76±10 
(56-96) 
72±7 
(57-84) 
0.305 
Total Cholesterol 
(mg/dL) 3 
187±38 
(105-274) 
171±36 
(104-249) 
187±33 
(128-250) 
0.196 
HDL Cholesterol 
(mg/dL) 
37±9b 
(20-58) 
47±10a 
(18-67) 
47±12a 
(30-71) 
0.001 
LDL Cholesterol 
(mg/dL) 3 
118±27 
(62-184) 
105±31 
(50-174) 
117±29 
(67-188) 
0.230 
Total/HDL 
Cholesterol Ratio 3 
5.2±1.2a 
(3.5-8.2) 
3.6±1.9b 
(2.4-6.3) 
4.3±1.5b 
(2.5-7.8) 
0.000 
LDL/HDL 
Cholesterol Ratio 3 
3.3±0.8a 
(2.2-5.2) 
2.2±0.8b 
(1.2-4.4) 
2.7±1.1b 
(1.3-5.2) 
0.001 
Triglycerides 
(mg/dL) 3 
138±67a 
(47-266) 
89±32b 
(48-178) 
116±70ab 
(40-273) 
0.011 
hsCRP (mg/L) 3 
3.7±3.5 
(0.2-13.9) 
3.0±3.3 
(0.1-14.1) 
2.8±2.8 
(0.2-10.3) 
0.625 
Fasting Plasma 
Glucose (mg/dL) 3 
94±7a 
(80-107) 
92±7ab 
(82-109) 
89±5b 
(81-98) 
0.030 
Insulin (µIU/mL) 
10.4±7.1 
(2.0-25.3) 
8.4±5.3 
(2.0-22.6) 
7.2±4.4 
(2.0-16.7) 
0.145 
HOMA 
2.5±1.6 
(0.5-5.9) 
1.9±1.3 
(0.4-5.5) 
1.6±1.0 
(0.4-3.5) 
0.088 
1 - Data displayed as Mean ± SD (Range).  Mean values with different 
superscripts are significantly different 
2 - Mean values were compared using an ANOVA test with LSD post-hoc 
3 - Data more than 3 SD from the mean were excluded 
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Table 7. Cardiometabolic disease risk factors stratified by 
participants’ employment status1 
 
Employed 
(n=45) 
Not 
Employed 
(n=28) 
p-
value2 
Employed 
Full Time  
(n=35) 
Employed 
Part Time 
(n=10) 
p-
value2 
Weight (kg) 
78±17 
(50-127) 
77±15 
(53-120) 
0.777 
78±17 
(50-127) 
79±17 
(53-103) 
0.859 
BMI (kg/m2) 3 
28.5±5.1 
(19.9-38.8) 
28.9±4.7 
(20.5-38.7) 
0.753 
28.3±5.2 
(19.9-38.8) 
29.4±5.2 
(21.2-37.0) 
0.568 
Waist 
Circumference 
(cm) 
95±14 
(73-130) 
95±12 
(67-117) 
0.812 
95±15 
(73-130) 
97±11 
(80-113) 
0.611 
Percent Body Fat 
(%) 
33.9±9.3 
(19.4-53.3) 
34.1±9.1 
(18.1-50.4) 
0.936 
33.7±9.3 
(19.4-53.3) 
34.4±9.6 
(23.7-48.5) 
0.857 
Systolic Blood 
Pressure  
(mm Hg) 
118±11 
(100-138) 
115±12 
(87-137) 
0.304 
118±11 
(100-138) 
115±7 
(102-126) 
0.391 
Diastolic Blood 
Pressure  
(mm Hg) 3 
74±8 
(60-96) 
73±10 
(56-95) 
0.661 
74±8 
(60-96) 
74±6 
(62-89) 
0.916 
Total Cholesterol 
(mg/dL) 3 
186±34 
(115-274) 
172±39 
(104-262) 
0.134 
189±38 
(115-274) 
177±17 
(153-209) 
0.149 
HDL Cholesterol 
(mg/dL) 
46±10 
(25-71) 
40±12 
(18-70) 
0.024 
48±10 
(25-71) 
40±9 
(30-56) 
0.051 
LDL Cholesterol 
(mg/dL) 3 
116±28 
(62-188) 
107±32 
(50-174) 
0.205 
119±31 
(62-188) 
108±10 
(91-125) 
0.085 
Total/HDL 
Cholesterol Ratio 3 
4.2±1.2 
(2.5-7.8) 
4.6±1.6 
(2.4-8.2) 
0.310 
4.1±1.2 
(2.5-7.8) 
4.6±1.3 
(3.1-7.1) 
0.278 
LDL/HDL 
Cholesterol Ratio 3 
2.7±0.9 
(1.3-5.2) 
2.8±1.1 
(1.2-5.2) 
0.754 
2.7±0.9 
(1.3-5.2) 
2.8±0.8 
(1.8-4.2) 
0.679 
Triglycerides 
(mg/dL) 3 
108±61 
(40-273) 
125±61 
(48-266) 
0.240 
99±51 
(40-256) 
142±83 
(62-273) 
0.144 
hsCRP (mg/L) 3 
3.4±3.5 
(0.2-14.1) 
2.8±2.6 
(0.1-9.7) 
0.447 
3.3±3.3 
(0.2-14.1) 
4.3±1.4 
(0.3-13.9) 
0.805 
Fasting Plasma 
Glucose (mg/dL) 3 
91±6 
(81-104) 
93±8 
(80-109) 
0.262 
91±6 
(82-104) 
91±6 
(81-97) 
0.974 
Insulin (µIU/mL) 
8.3±5.7 
(2.0-25.1) 
9.5±6.1 
(2.0-25.3) 
0.387 
8.4±5.2 
(2.0-22.6) 
7.9±7.2 
(2.0-25.1) 
0.814 
HOMA 
1.9±1.3 
(0.4-5.9) 
2.2±1.4 
(0.4-5.7) 
0.301 
1.9±1.2 
(0.4-5.5) 
1.8±1.8 
(0.4-5.9) 
0.767 
1 - Data displayed as Mean ± SD (Range) 
2 - Mean values for employment were compared using an independent samples t-test. 
3 - Data more than 3 SD from the mean were excluded 
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Table 8. Cardiometabolic risk and acculturation category1 
 Mexican 
1 
(n=25) 
2 
(n=15) 
3 
(n=21) 
4 
(n=12) 
Anglo 
5 
(n=0) 
p-
value2 
Weight (kg) 
77±13 
(53-103) 
79±15 
(53-99) 
81±16 
(58-127) 
72±17 
(50-102) 
N/A 0.409 
BMI (kg/m2) 3 
29.4±5.0 
(20.5-38.5) 
28.9±5.3 
(21.2-38.7) 
28.7±4.1 
(22.1-36.3) 
26.4±5.6 
(19.9-38.8) 
N/A 0.398 
Waist 
Circumference 
(cm) 
94±12 
(67-113) 
95±13 
(71-115) 
97±13 
(73-124) 
91±16 
(73-130) 
N/A 0.593 
Percent Body Fat 
(%) 
37.3±8.9 
(20.4-50.4) 
30.5±9.4 
(18.1-47.0) 
33.7±9.1 
(21.1-53.3) 
31.3±8.6 
(21.4-48.9) 
N/A 0.091 
Systolic Blood 
Pressure  
(mm Hg) 
115±11 
(98-137) 
115±14 
(87-136) 
117±10 
(100-135) 
120±12 
(101-138) 
N/A 0.677 
Diastolic Blood 
Pressure  
(mm Hg) 3 
73±10 
(56-95) 
74±9 
(62-90) 
74±6 
(62-85) 
77±9 
(64-96) 
N/A 0.691 
Total Cholesterol 
(mg/dL) 3 
193±33 
(153-262) 
175±39 
(117-274) 
166±38 
(104-229) 
186±33 
(153-250) 
N/A 0.089 
HDL Cholesterol 
(mg/dL) 
42±7 
(29-58) 
44±12 
(25-70) 
44±14 
(18-71) 
47±12 
(31-66) 
N/A 0.730 
LDL Cholesterol 
(mg/dL) 3 
123±27 
(93-184) 
102±27 
(56-151) 
103±29 
(50-159) 
115±34 
(79-188) 
N/A 0.062 
Total/HDL 
Cholesterol Ratio 3 
4.7±1.1 
(3.2-7.1) 
4.3±1.4 
(2.4-6.3) 
4.0±1.4 
(2.6-8.2) 
4.3±1.7 
(2.5-7.8) 
N/A 0.348 
LDL/HDL 
Cholesterol Ratio 3 
3.0±0.7 
(1.9-4.5) 
2.7±1.1 
(1.2-4.9) 
2.3±0.7 
(1.3-4.1) 
2.7±1.3 
(1.3-5.2) 
N/A 0.126 
Triglycerides 
(mg/dL) 3 
135±67 
(50-273) 
108±63 
(48-245) 
90±40 
(40-174) 
119±69 
(53-259) 
N/A 0.092 
hsCRP (mg/L) 3 
3.7±3.6 
(0.3-13.9) 
2.2±2.1 
(0.1-6.8) 
3.8±3.8 
(0.2-14.1) 
2.6±2.6 
(0.2-8.1) 
N/A 0.402 
Fasting Plasma 
Glucose (mg/dL) 3 
95±8 
(80-109) 
90±6 
(81-102) 
92±6 
(82-103) 
90±5 
(81-99) 
N/A 0.093 
Insulin (µIU/mL) 
9.0±6.0 
(2.0-25.1) 
7.7±5.8 
(2.0-25.3) 
8.3±4.7 
(2.0-16.9) 
8.6±6.6 
(2.0-22.6) 
N/A 0.915 
HOMA 
2.1±1.4 
(0.5-5.9) 
1.7±1.3 
(0.4-5.5) 
1.9±1.1 
(0.4-3.8) 
1.9±1.6 
(0.4-5.5) 
N/A 0.829 
1 - Data displayed as Mean ± SD (Range).  Mean values with different superscripts are 
significantly different 
2 - Mean values were compared using an ANOVA test with LSD post-hoc 
3 - Data more than 3 SD from the mean were excluded 
N/A – No participant is categorized as a 5 
 
89 
 
Table 9. Daily macronutrient consumption of study participants1 
 Characteristics 
All  
(n=75) 
 Men  
(n=26) 
Women 
(n=49) 
p value2 
Total Energy (kcal) 2587±1598 
 
3140±1997 2293±1267 0.057 
Macronutrient amounts (g) 
Total Fat 3 89±56 
 
108±66 79±48 0.037 
SFA 3 30±19 
 
35±22 32±17 0.114 
MUFA 3 34.2±20.8 
 
40.0±22.0 31.3±19.7 0.089 
PUFA 3 16.6±10.0 
 
19.7±11.9 15.0±8.6 0.059 
Trans Fatty Acids 3 1.5±1.2 
 
1.8±1.5 1.3±1.0 0.137 
Carbohydrates 3 345±224 
 
416±292 307±169 0.089 
Sugar 3 151±126 
 
191±174 129±85 0.097 
Protein 3 109±70 
 
134±89 96±54 0.056 
Energy contribution from macronutrients (% energy) 
Total Fat 31±5 
 
32±5 30±5 0.356 
SFA 10.3±2.2 
 
10.2±2.3 10.3±2.1 0.801 
MUFA 12.1±1.9 
 
12.5±2.0 11.9±1.9 0.173 
PUFA 6.1±1.2 
 
6.4±1.3 5.9±1.1 0.078 
Trans Fatty Acids 0.51±0.2 
 
0.50±0.2 0.52±0.2 0.688 
Carbohydrates 53±7 
 
52±8 54±6 0.153 
Sugar 23±6 
 
22±6 23±6 0.660 
Protein 17±3 
 
17±3 17±2 0.496 
1 - Data displayed as Mean ± SD 
2 - Mean values for men and women were compared using an independent samples t-test. 
3 - Data more than 3 SD from the mean were excluded 
SFA=Saturated Fatty Acids, MUFA=Monounsaturated Fatty Acids, PUFA=Polyunsaturated Fatty 
Acids 
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Table 10. Macronutrient consumption stratified by income1 
 
$0-1000 
(n=17) 
$1001-
2000 
(n=18) 
$2001-
3000 
(n=15) 
$3001-
4000 
(n=9) 
>$4000 
(n=15) 
p-
value2 
Total Energy 
(kcal) 3 
2387±1360 
(498-5036) 
2506±1144 
(495-4512) 
2934±1946 
(884-6495) 
2179±1513 
(1070-5575) 
2210±929 
(852-3997) 
0.645 
Macronutrient amounts (g) 
Total Fat 3 
84±50 
(11-192) 
88±48 
(16-191) 
103±62 
(25-213) 
87±76 
(34-238) 
75±34 
(30-143) 
0.737 
SFA 3 
28±16 
(4-57) 
30±18 
(5-78) 
35±20 
(9-69) 
27±24 
(11-69) 
25±12 
(10-50) 
0.661 
MUFA 3 
33.4±20.0 
(4.1-75.6) 
34.9±18.6 
(6.0-72.7) 
40.8±25.2 
(9.0-82.4) 
33.8±29.6 
(13.9-92.8) 
29.5±13.9 
(11.3-58.8) 
0.711 
PUFA 3 
16.8±10.7 
(2.6-43.7) 
17.0±9.5 
(2.7-36.9) 
17.6±9.9 
(4.7-34.3) 
17.6±15.3 
(5.7-52.3) 
14.7±6.5 
(6.2-30.1) 
0.947 
Trans Fatty 
Acids 3 
1.0±0.6b 
(0.2-2.1) 
1.3±0.9b 
(0.2-3.8) 
2.1±1.5a 
(0.4-4.9) 
1.2±0.8b 
(0.6-3.0) 
1.4±1.0b 
(0.3-4.2) 
0.047 
Carbohydrates 3 
314±198 
(89-862) 
331±152 
(64-650) 
417±307 
(125-974) 
309±206 
(145-771) 
299±123 
(110-527) 
0.532 
Sugar 3 
127±83 
(45-320) 
145±90 
(25-378) 
184±155 
(60-461) 
129±96 
(54-355) 
125±63 
(44-290) 
0.481 
Protein 3 
98±54 
(15-195) 
106±49 
(27-198) 
122±77 
(40-286) 
116±93 
(48-292) 
94±41 
(35-159) 
0.714 
Energy contribution from macronutrients (% energy) 
Total Fat 
31±6 
(20-42) 
31±5 
(25-39) 
32±5 
(25-41) 
27±2 
(24-31) 
31±4 
(23-37) 
0.144 
SFA 
10.4±2.3 
(6-14) 
10.3±2.4 
(6-16) 
11.1±2.0 
(9-15) 
8.7±1.4 
(7-11) 
10.2±2.1 
(8-15) 
0.120 
MUFA 
12.4±2.6 
(7-18) 
12.3±1.9 
(9-16) 
12.7±1.8 
(9-15) 
10.6±0.9 
(9-12) 
11.9±1.5 
(9-14) 
0.104 
PUFA 
6.2±1.3 
(4-9) 
5.9±1.2 
(4-9) 
6.3±1.3 
(4-8) 
5.6±1.1 
(4-8) 
6.1±1.2 
(4-9) 
0.720 
Trans Fatty 
Acids 
0.5±0.3 
(0.2-1.4) 
0.5±0.2 
(0.3-1.0) 
0.6±0.3 
(0.2-1.2) 
0.4±0.2 
(0.2-0.8) 
0.6±0.3 
(0.2-1.1) 
0.238 
Carbohydrates 
53±9 
(38-72) 
53±7 
(45-66) 
50±7 
(40-61) 
58±4 
(54-67) 
54±4 
(46-63) 
0.158 
Sugar 
21±6 
(13-36) 
23±7 
(13-37) 
22±6 
(10-35) 
26±8 
(13-40) 
23±6 
(16-35) 
0.491 
Protein 
17±3 
(12-22) 
17±3 
(12-25) 
18±3 
(14-25) 
17±2 
(12-19) 
17±1 
(14-20) 
0.758 
1 - Data displayed as Mean ± SD (Range).  Mean values with different superscripts are 
significantly different 
2 - Mean values were compared using an ANOVA test with LSD post-hoc 
3 - Data more than 3 SD from the mean were excluded 
SFA=Saturated Fatty Acids, MUFA=Monounsaturated Fatty Acids, PUFA=Polyunsaturated 
Fatty Acids 
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Table 11. Macronutrient consumption 
stratified by income category1 
 ≤$3000 
(n=50) 
>$3000 
(n=24)2 
p-
value3 
Total Energy 
(kcal) 4 
2587±1469 
(495-6495) 
2199±1130 
(852-5575) 
0.267 
Macronutrient amounts (g) 
Total Fat 4 
91±52 
(12-213) 
80±52 
(30-238) 
0.382 
SFA 4 
31±18 
(4-78) 
26±17 
(10-69) 
0.287 
MUFA 4 
36±21 
(4-82) 
31±21 
(11-93) 
0.516 
PUFA 4 
17±10 
(3-44) 
16±10 
(6-52) 
0.341 
Trans Fatty 
Acids 4 
1.5±1.2 
(0.2-4.9) 
1.3±0.9 
(0.3-4.2) 
0.621 
Carbohydrates 4 
351±223 
(64-974) 
302±152 
(110-771) 
0.343 
Sugar 4 
151±111 
(25-461) 
126±74 
(44-355) 
0.340 
Protein 4 
108±59 
(15-286) 
102±65 
(35-292) 
0.710 
Energy contribution from macronutrients  
(% energy) 
Total Fat 
32±5 
(20-42) 
29±3 
(23-37) 
0.042 
SFA 
10.6±2.2 
(6.1-15.5) 
9.6±2.0 
(6.8-15.1) 
0.073 
MUFA 
12.4±2.1 
(7.4-17.6) 
11.4±1.4 
(9.0-13.7) 
0.031 
PUFA 
6.1±1.2 
(4.1-8.6) 
5.9±1.2 
(3.9-9.2) 
0.520 
Trans Fatty 
Acids 
0.5±0.2 
(0.2-1.4) 
0.5±0.2 
(0.2-1.1) 
0.937 
Carbohydrates 
52±8 
(38-72) 
56±4 
(46-67) 
0.027 
Sugar 
22±6 
(10-37) 
24±7 
(13-40) 
0.244 
Protein 
17±3 
(11-25) 
17±2 
(12-20) 
0.625 
1 - Data displayed as Mean ± SD (Range) 
2 - Data for one participant not available 
3 - Mean values for income categories were 
compared using an independent samples t-test 
4 - Data more than 3 SD from the mean were 
excluded 
SFA=Saturated Fatty Acids, MUFA=Monounsaturated 
Fatty Acids, PUFA=Polyunsaturated Fatty Acids 
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Table 12. Macronutrient consumption stratified by education1 
 
Completed 
Elementary 
(n=4) 
Completed 
Middle 
Sch. 
(n=11) 
Completed 
High 
School 
(n=11) 
Some 
College 
(n=27) 
College 
Grad or 
Higher 
(n=22) 
p-
value2 
Total Energy 
(kcal) 3 
1476±71 
(1401-1542) 
2733±1604 
(498-5232) 
2508±1828 
(495-6395) 
2312±1151 
(852-4561) 
2585±1376 
(959-6495) 
0.666 
Macronutrient amounts (g) 
Total Fat 3 
99±93 
(43-238) 
90±59 
(11-198) 
76±50 
(16-183) 
84±48 
(25-192) 
91±50 
(30-213) 
0.927 
SFA 3 
30±26 
(13-68) 
30±21 
(4-69) 
26±17 
(5-61) 
28±17 
(9-78) 
31±17 
(9-69) 
0.969 
MUFA 3 
39.4±35.9 
(17.4-92.8) 
37.5±25.2 
(4.1-82.4) 
31.1±21.3 
(6.0-78.0) 
32.8±18.9 
(9.0-75.6) 
35.1±19.2 
(11.9-76.7) 
0.930 
PUFA 3 
21.2±20.7 
(9.6-52.3) 
17.0±10.1 
(2.6-34.3) 
13.9±10.0 
(2.7-34.2) 
17.1±9.8 
(4.7-43.7) 
16.1±8.0 
(5.7-32.6) 
0.783 
Trans Fatty 
Acids 3 
1.3±1.1 
(0.4-3.0) 
1.7±1.6 
(0.2-4.9) 
1.2±1.0 
(0.2-3.8) 
1.3±0.8 
(0.4-4.2) 
1.5±1.0 
(0.3-4.3) 
0.822 
Carbohydrates 3 
192±57 
(132-245) 
429±269 
(89-961) 
363±299 
(64-974) 
295±145 
(110-650) 
337±173 
(135-792) 
0.283 
Sugar 3 
66±22 
(45-90) 
171±136 
(45-448) 
159±123 
(25-419) 
131±85 
(44-378) 
142±95 
(46-461) 
0.524 
Protein 3 
117±116 
(54-292) 
128±82 
(15-286) 
105±66 
(27-240) 
95±48 
(35-198) 
104±50 
(33-249) 
0.674 
Energy contribution from macronutrients (% energy) 
Total Fat 
31±8 
(25-42) 
29±5 
(21-36) 
29±5 
(20-36) 
32±4 
(24-38) 
31±5 
(23-41) 
0.256 
SFA 
9.7±2.5 
(7-13) 
9.3±2.1 
(6-12) 
10.0±2.2 
(6-13) 
10.6±2.1 
(7-16) 
10.5±2.3 
(8-15) 
0.477 
MUFA 
12.6±3.4 
(10-18) 
11.8±2.0 
(7-15) 
11.6±1.7 
(9-15) 
12.4±1.7 
(9-15) 
12.1±2.0 
(9-16) 
0.737 
PUFA 
6.5±1.2ab 
(6-8) 
5.7±0.8bc 
(4-7) 
5.1±0.8c 
(4-6) 
6.5±1.1a 
(5-9) 
6.1±1.4ab 
(4-9) 
0.007 
Trans Fatty 
Acids 
0.4±0.2 
(0.2-0.7) 
0.4±0.2 
(0.2-0.8) 
0.4±0.2 
(0.3-0.9) 
0.6±0.3 
(0.3-1.4) 
0.5±0.2 
(0.2-1.2) 
0.252 
Carbohydrates 
54±11 
(38-64) 
56±8 
(44-72) 
55±8 
(40-68) 
52±6 
(42-67) 
53±6 
(42-63) 
0.436 
Sugar 
23±12 
(13-40) 
22±8 
(10-36) 
24±5 
(18-34) 
22±6 
(13-37) 
22±6 
(15-35) 
0.876 
Protein 
16±2 
(14-18) 
16±3 
(12-25) 
18±4 
(11-24) 
17±2 
(12-20) 
18±2 
(14-25) 
0.185 
1 - Data displayed as Mean ± SD (Range).  Mean values with different superscripts are 
significantly different 
2 - Mean values were compared using an ANOVA test with LSD post-hoc 
3 - Data more than 3 SD from the mean were excluded 
SFA=Saturated Fatty Acids, MUFA=Monounsaturated Fatty Acids, PUFA=Polyunsaturated Fatty 
Acids 
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Table 13. Macronutrient consumption stratified by 
completion of high school1 
 Completed 
Elementary, 
Middle, or 
High School 
(n=26) 
Some 
College 
(n=27) 
College 
Graduate or 
Higher 
(n=22) 
p-
value2 
Total Energy 
(kcal) 3 
2473±1619 
(495-6395) 
2312±1151 
(852-4561) 
2585±1376 
(959-6495) 
0.786 
Macronutrient amounts (g) 
Total Fat 3 
86±59 
(11-238) 
84±48 
(25-192) 
91±50 
(30-213) 
0.913 
SFA 3 
28±19 
(4-69) 
28±17 
(9-78) 
31±17 
(9-69) 
0.869 
MUFA 3 
35.0±34.5 
(4.1-92.8) 
32.8±18.9 
(9.0-75.6) 
35.1±19.2 
(11.9-76.7) 
0.908 
PUFA 3 
16.3±11.9 
(2.6-52.3) 
17.1±9.8 
(4.7-43.7) 
16.1±8.0 
(5.7-32.6) 
0.939 
Trans Fatty Acids 3 
1.4±1.3 
(0.2-4.9) 
1.3±0.8 
(0.4-4.2) 
1.5±1.0 
(0.3-4.3) 
0.868 
Carbohydrates 3 
371±271 
(64-974) 
295±145 
(110-650) 
337±173 
(135-792) 
0.404 
Sugar 3 
153±123 
(25-448) 
131±85 
(44-378) 
142±95 
(46-461) 
0.734 
Protein 3 
117±78 
(15-292) 
95±48 
(35-198) 
104±50 
(33-249) 
0.444 
Energy contribution from macronutrients (% energy) 
Total Fat 
29±5 
(20-42) 
32±4 
(24-38) 
31±5 
(23-41) 
0.104 
SFA 
9.7±2.1 
(6.1-13.1) 
10.6±2.1 
(6.8-15.5) 
10.5±2.3 
(7.7-15.2) 
0.219 
MUFA 
11.8±2.1 
(7.4-17.6) 
12.4±1.7 
(9.2-14.9) 
12.1±2.0 
(9.0-16.1) 
0.543 
PUFA 
5.6±1.0b 
(4.1-8.3) 
6.5±1.1a 
(4.8-8.6) 
6.1±1.4ab 
(3.9-9.2) 
0.010 
Trans Fatty Acids 
0.4±0.2 
(0.2-0.9) 
0.6±0.3 
(0.3-1.4) 
0.5±0.2 
(0.2-1.2) 
0.067 
Carbohydrates 
55±8 
(38-72) 
52±6 
(42-67) 
53±6 
(42-63) 
0.181 
Sugar 
23±7 
(10-40) 
22±6 
(13-37) 
22±6 
(15-35) 
0.806 
Protein 
17±4 
(11-25) 
17±2 
(12-20) 
18±2 
(14-25) 
0.381 
1 - Data displayed as Mean ± SD (Range).  Mean values with different 
superscripts are significantly different 
2 - Mean values were compared using an ANOVA test with LSD post-hoc 
3 - Data more than 3 SD from the mean were excluded 
SFA=Saturated Fatty Acids, MUFA=Monounsaturated Fatty Acids, 
PUFA=Polyunsaturated Fatty Acids 
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Table 14. Macronutrient consumption stratified by employment1 
 
Employed 
(n=45) 
Not 
Employed 
(n=28) 
p-
value2 
Employed 
Full Time 
(n=35) 
Employed 
Part Time 
(n=10) 
p-
value2 
Total Energy 
(kcal) 3 
2431±1423 
(495-6495) 
2389±1303 
(498-6395) 
0.901 
2414±1401 
(495-6495) 
2488±1572 
(1300-5575) 
0.887 
Macronutrient amounts (g) 
Total Fat 3 
82±52 
(16-213) 
91±53 
(11-238) 
0.461 
82±50 
(16-213) 
83±60 
(37-198) 
0.941 
SFA 3 
27±17 
(5-69) 
31±18 
(4-78) 
0.312 
26±16 
(5-62) 
29±22 
(11-69) 
0.614 
MUFA 3 
30.5±17.6 
(9.0-78.0) 
40.3±24.2 
(4.1-92.8) 
0.068 
30.3±18.2 
(9.0-78.0) 
31.2±16.4 
(13.9-59.8) 
0.889 
PUFA 3 
14.5±7.4 
(4.7-34.2) 
19.8±12.6 
(2.6-52.3) 
0.049 
14.2±7.3 
(4.7-34.2) 
15.6±8.0 
(5.7-27.5) 
0.615 
Trans Fatty 
Acids 3 
1.3±1.1 
(0.2-4.9) 
1.5±1.0 
(0.2-4.3) 
0.468 
1.4±1.1 
(0.2-4.9) 
1.2±1.2 
(0.4-4.4) 
0.598 
Carbohydrates 3 
341±210 
(64-974) 
309±194 
(89-974) 
0.523 
342±215 
(64-961) 
338±200 
(186-771) 
0.966 
Sugar 3 
145±107 
(25-461) 
131±93 
(45-419) 
0.587 
149±113 
(25-461) 
131±85 
(59-355) 
0.649 
Protein 3 
102±62 
(27-286) 
108±60 
(15-292) 
0.668 
99±60 
(27-286) 
110±70 
(47-249) 
0.635 
Energy contribution from macronutrients (% energy) 
Total Fat 
30±4 
(20-38) 
32±6 
(21-42) 
0.071 
30±4 
(20-38) 
29±3 
(24-34) 
0.433 
SFA 
9.8±1.8 
(6.1-13.0) 
11.0±2.6 
(6.4-15.5) 
0.023 
9.7±1.8 
(6.1-12.7) 
10.1±1.9 
(7.2-13.0) 
0.639 
MUFA 
11.8±1.6 
(8.6-14.9) 
12.6±2.4 
(7.4-17.6) 
0.093 
11.9±1.6 
(8.6-14.9) 
11.1±1.5 
(9.3-14.2) 
0.175 
PUFA 
6.0±1.2 
(3.9-8.6) 
6.2±1.3 
(4.3-9.2) 
0.536 
6.1±1.1 
(3.9-8.6) 
5.6±1.3 
(4.1-8.2) 
0.229 
Trans Fatty 
Acids 
0.5±0.2 
(0.2-1.2) 
0.5±0.2 
(0.2-1.4) 
0.241 
0.6±0.2 
(0.2-1.2) 
0.5±0.2 
(0.2-1.0) 
0.202 
Carbohydrates 
54±6 
(42-68) 
51±8 
(38-72) 
0.080 
54±7 
(42-68) 
56±5 
(49-65) 
0.514 
Sugar 
23±6 
(10-37) 
22±7 
(13-40) 
0.877 
23±6 
(13-37) 
22±7 
(10-31) 
0.794 
Protein 
17±3 
(11-25) 
17±2 
(12-24) 
0.624 
17±3 
(11-25) 
18±2 
(13-22) 
0.446 
1 - Data displayed as Mean ± SD (Range) 
2 - Mean values for employment were compared using an independent samples t-test. 
3 - Data more than 3 SD from the mean were excluded 
SFA=Saturated Fatty Acids, MUFA=Monounsaturated Fatty Acids, PUFA=Polyunsaturated Fatty 
Acids 
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Table 15. Macronutrient consumption stratified by acculturation 
category1 
 Mexican 
1 
(n=25) 
2 
(n=15) 
3 
(n=21) 
4 
(n=12) 
Anglo 
5 
(n=0) 
p-
value 
Total Energy 
(kcal) 3 
2570±1258 
(495-5232) 
2560±1723 
(959-6395) 
2542±1515 
(884-6495) 
2082±941 
(852-3997) 
N/A 0.761 
Macronutrient amounts (g) 
Total Fat 3 
89±47 
(11-198) 
85±61 
(30-191) 
99±61 
(25-238) 
70±36 
(30-143) 
N/A 0.530 
SFA 3 
30±16 
(4-69) 
29±23 
(9-78) 
32±18 
(9-68) 
23±12 
(10-44) 
N/A 0.613 
MUFA 3 
35.4±19.6 
(4.1-82.4) 
34.4±24.3 
(11.9-78.0) 
38.2±23.3 
(9.0-92.8) 
26.9±14.5 
(11.4-58.8) 
N/A 0.532 
PUFA 3 
16.5±8.6 
(2.6-34.3) 
16.4±11.2 
(5.7-36.9) 
19.0±12.4 
(4.7-52.3) 
14.0±7.6 
(6.2-30.1) 
N/A 0.617 
Trans Fatty 
Acids 3 
1.4±1.0 
(1.2-4.4) 
1.1±0.9 
(0.4-3.8) 
1.7±1.2 
(0.4-4.9) 
1.3±1.0 
(0.3-4.2) 
N/A 0.454 
Carbohydrates 3 
344±173 
(64-650) 
354±243 
(135-974) 
356±249 
(125-961) 
280±123 
(110-527) 
N/A 0.752 
Sugar 3 
141±89 
(25-378) 
158±119 
(46-419) 
149±120 
(60-461) 
125±72 
(44-290) 
N/A 0.858 
Protein 3 
108±52 
(15-221) 
108±73 
(33-249) 
114±72 
(34-292) 
89±43 
(36-159) 
N/A 0.741 
Energy contribution from macronutrients (% energy) 
Total Fat 
30±4 
(21-40) 
29±4 
(25-38) 
32±5 
(20-41) 
30±5 
(23-37) 
N/A 0.210 
SFA 
10.2±1.8 
(6.4-13.7) 
9.8±2.4 
(6.1-15.5) 
10.7±2.3 
(6.7-15.2) 
10.0±2.6 
(6.8-15.1) 
N/A 0.602 
MUFA 
12.0±2.0 
(7.4-16.1) 
11.8±1.3 
(9.9-14.5) 
12.5±2.1 
(8.6-15.2) 
11.5±1.6 
(9.0-13.8) 
N/A 0.399 
PUFA 
5.7±0.9 
(4.3-8.0) 
5.8±1.3 
(4.1-8.6) 
6.6±1.1 
(4.3-8.6) 
6.0±1.4 
(3.9-9.2) 
N/A 0.050 
Trans Fatty 
Acids 
0.5±0.2 
(0.2-1.0) 
0.4±0.1 
(0.2-0.6) 
0.6±0.3 
(0.3-1.4) 
0.6±0.3 
(0.2-1.1) 
N/A 0.071 
Carbohydrates 
54±7 
(44-72) 
56±6 
(47-66) 
51±7 
(40-68) 
54±6 
(46-67) 
N/A 0.241 
Sugar 
22±7 
(10-37) 
24±5 
(13-34) 
22±6 
(15-40) 
24±7 
(13-35) 
N/A 0.791 
Protein 
17±3 
(12-25) 
17±3 
(11-22) 
17±3 
(13-25) 
17±2 
(12-20) 
N/A 0.991 
1 - Data displayed as Mean ± SD (Range).  Mean values with different superscripts are 
significantly different 
2 - Mean values were compared using an ANOVA test with LSD post-hoc 
3 - Data more than 3 SD from the mean were excluded 
N/A – No participant is categorized as a 5 
SFA=Saturated Fatty Acids, MUFA=Monounsaturated Fatty Acids, PUFA=Polyunsaturated Fatty 
Acids 
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DISCUSSION 
Cardiovascular disease is a rising health problem and the main 
cause of death among Mexican-Americans.  There are multiple 
factors that can contribute to the risk of developing CVD that 
include, but are not limited to, dyslipidemia, elevated glucose, 
elevated hsCRP, hypertension, increased adiposity, and 
macronutrient consumption.  Despite some indication that non-
biological risk factors negatively affect diet and chronic disease 
risk [16-20, 34, 61, 71, 121-124], specific information among 
Mexican Americans is scarce.  Therefore, the purpose of this 
work was to perform a cross-sectional evaluation of self-reported 
individual and family dietary and lifestyle habits, sociocultural 
factors (income, employment, acculturation, and education) and 
biological markers of cardiometabolic risk among Mexican-
American adults living in the Phoenix metropolitan area.  The 
relevance of this work lies on the pressing need to aid in the 
elimination of health disparities by focusing on chronic disease 
risk reduction and prevention, and not just on disease 
treatment. 
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Income, diet and CVD risk factors in Mexican-American 
adults 
Several studies have documented greater CVD risk among 
individuals with a lower socioeconomic status [7, 17, 122, 126, 
127, 129, 130].  In the current study, participants with higher 
household income (greater than $3000 per month) had 27% 
lower weight, 18% lower BMI, and 17% smaller waist 
circumference than those with lower household incomes.  In 
particular, these indicators of adiposity were significantly greater 
among participants with a household income lower than $1000 
per month or between $2001 and $3000 per month.  
Interestingly, weight, BMI and waist circumference of 
participants earning between $1001 and $2000 per month did 
not differ from those of individuals earning more than $3000 per 
month.  In agreement with our findings, Appel et al. [122] 
explored the relationship between sociodemographics and CVD 
risk in 1,110 participants and found a significant negative 
association between income and CVD risk.  Similarly, Robert et 
al. [17] reported a negative association between income and 
BMI.  Kavanagh et al. [127] also reported a negative association 
between income and waist circumference, dyslipidemia, and 
blood pressure.  Unlike Appel et al. [122] CVD risk was not 
99 
 
categorized according to the various risk factors associated with 
CVD. 
 
Regarding biomarkers of cardiometabolic risk, after grouping the 
participants in our study into two income categories (≤$3000 
and >$3000), those earning less than $3000 per month had 3% 
significantly higher fasting glucose, 52% higher insulin, and 47% 
higher HOMA than those earning more than $3000 per month.  
As previously established, having greater HOMA scores is 
associated with greater CVD risk.  One study by Strufaldi et al. 
[185] looked at the relationship between HOMA values and CVD 
risk factors.  Participants were divided into tertiles based on 
HOMA values (Tertile 1, 0.32-0.53; Tertile 2, 0.55-1.10; Tertile 
3, 1.16-6.01).  Those in the lowest tertile of HOMA score had a 
significantly lower number of risk factors for CVD than those in 
the highest tertile.  No participants in Tertile 1 had increased 
insulin compared to 83% of participants in Tertile 3.  Participants 
from Tertile 1 also had lower prevalence of high BMI (25% vs. 
48%, p=0.007), high blood pressure (13% vs. 61%, p=0.008), 
and low HDL cholesterol (22% vs. 51%, p=0.020) than those in 
Tertile 3.  Furthermore, Tertile 3 had higher incidence of 
elevated triglyceride concentration (concentrations ≥130 mg/dL, 
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27% vs. 50%) and elevated glucose concentrations 
(concentrations ≥100 mg/dL, 0% vs. 43%) than Tertile 1, 
although this data was not statistically significant. 
 
Barr et al. [186] documented that participants who were the 
least insulin sensitive according to HOMA were more than twice 
as likely to experience a CVD event as those who were the most 
insulin sensitive.   Smith et al. [187] documented that 
participants with a fasting serum glucose concentration ≤109 
mg/dL but who had an elevated 2-hour glucose concentration of 
≥200 mg/dL were 1.3 times as likely to have a CVD event than 
those who had a fasting serum glucose concentration  ≤109 
mg/dL and a 2-hour glucose concentration ≤139 mg/dL.  They 
also reported that participants with an impaired fasting serum 
glucose concentration (110-125 mg/dL) coupled with an elevated 
2-hour glucose concentration (≥200 mg/dL) were 2.2 times as 
likely to have a CVD event than those who had impaired fasting 
serum glucose concentrations and normal 2-hour glucose 
concentrations (≤139 mg/dL).   
 
Orencia et al. [188] explored the effect of high glucose 
concentrations of 39,573 non-diabetic participants following a 
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50-gram glucose load.  They reported that only 16% of those in 
the lowest quintile of glucose concentration 1-hour postprandial 
(39-121 mg/dL) had CVD whereas 27% of those in the highest 
quintile (144-700 mg/dL) had CVD.  Although these studies did 
not find a relationship between income and most CVD risk 
factors, our study found that those with a lower income had 
higher HOMA, insulin, and glucose.  Therefore, it is possible that 
having a lower income is associated with an increased risk for 
CVD since higher HOMA, insulin, and glucose concentrations are 
associated with increased CVD risk or CVD events [185-188]. 
 
The present study also found that HDL cholesterol was lower for 
those earning $3000 per month than those earning more than 
$3000 per month.  Kavanagh et al. [127] reported a positive 
association between income and HDL cholesterol concentrations 
(β=-0.09, p≤0.05), and Muennig et al. [129] documented that 
participants earning less than $20,000 annually have a lower 
HDL cholesterol concentration than those earning more than 
$20,000 annually (50.8 mg/dL vs. 51.6 mg/dL).  Although this 
shows that those with a lower income are more likely to also 
have a lower HDL cholesterol concentration, the difference is 
relatively small from a physiological point of view, and may not 
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dramatically change CVD risk.  It should also be noted that the 
income cutoff point used by Muennig et al. [129] was lower than 
that used in our study ($1667/month vs. $3000/month).  
However, it shows the positive association between income and 
HDL cholesterol concentrations. 
 
Steptoe et al. [140] explored the relationship between 
socioeconomic status and CVD.  After grouping participants 
based on their grade of employment (higher, intermediate, 
lower), they reported that higher socioeconomic status was 
related to a significantly smaller waist/hip ratio (0.90 vs, 0.93), 
higher HDL cholesterol concentrations (1.84 mmol/L vs. 1.53 
mmol/L), lower total/HDL cholesterol ratio (3.48 vs. 3.91), and 
lower fasting glucose concentrations (5.26 mmol/L vs. 5.76 
mmol/L).  Kavanagh et al. [127] documented a significant 
difference in blood pressure between high and low income 
participants (β=-2.09, p≤0.05).  Friedman and Herd [189] also 
explored the relationship between income and CVD risk.  Income 
was considered all pretax income and was adjusted for 
household size.  They also grouped participants into quintiles 
(Q1: ≤$17,838; Q2: $17,839-$35,037; Q3: $35,038-$50,161; 
Q4: $50,162-$76,809; Q5: ≥$76,810).  Friedman and Herd 
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found that hsCRP was significantly higher in the lowest income 
group than in the highest group (1.9 µg/mL vs. 1.1 µg/mL; 
β=0.19, p<0.001).  The income grouping used in these studies 
[127, 140, 189] was different than that used in our study, but it 
shows the positive association between income and CVD risk. 
 
The findings of our study concur with previous findings 
suggesting that persons with a higher income have fewer 
biological risk factors for CVD than those with a lower income.  
Even after grouping income into different categories our study 
was able to find negative associations between income and CVD 
risk factors.  However, our study did not find significant 
differences between total cholesterol, LDL cholesterol, 
triglycerides, total/HDL cholesterol ratio, LDL/HDL cholesterol 
ratios, or hsCRP when stratified by income.  Significant 
relationships were not found between income and percent body 
fat or blood pressure. 
 
In addition to relationships between income and cardiovascular 
disease risk factors, the present study found that income is 
associated with some aspects of the diet.  Participants earning 
less than $3000 per month had a higher percent of their energy 
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intake from total fat and monounsaturated fatty acids and a 
lower percent of their energy intake from carbohydrates than 
those earning more than $3000 per month (32% vs. 29% 
energy from total fat; 12.4% vs. 11.4% energy from 
monounsaturated fatty acids; 52% vs. 56% energy from 
carbohydrates).  Moreover, participants earning between $2001 
and $3000 per month had a significantly greater intake of trans 
fatty acids than those in the lowest income bracket (2.1g vs. 
1.0g).  Although this difference in percent energy from total fat, 
monounsaturated fatty acids, and trans fatty acid intake is 
statistically significant, it may not be physiologically relevant.  
For example, considering that our study participants’ mean 
energy intake was 2587±1598 kilocalories per day, the 
difference between 32% and 29% energy from fat is equivalent 
to consuming 78 kilocalories (8.7 g) more from fat.  
 
The differences noted above could be attributed to eating out 
more frequently rather than eating homemade meals.  Another 
factor with eating out of the home is where someone eats and 
what they order.  Additionally, one speculation might be that 
those earning less than $3000 per month felt they were too busy 
to make homemade meals and found eating out more 
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convenient.  Another contributing factor to the larger intake of 
trans fatty acids is the cost of healthy foods when compared with 
energy dense foods.  There is an inverse relationship between 
energy density (kcal/gram) and energy cost (cost/kcal) [161].  
Although the total package price and unit price of produce may 
be lower than those of snacks, the average per serving price for 
produce can be higher than for snack foods that are potentially 
higher in trans fatty acids [161].  Thus, those with a higher 
income are better able to pay the higher price for produce and 
healthy food options.   
 
One study reported that in a particular low-income community 
there were only 2 stores that provided enough variety of foods 
for consumers to be able to meet the recommended dietary 
guidelines [190].  This suggests that low-income areas may not 
have access to healthy food options even if they can afford 
them.   
 
Simon et al. [191] explored the number of fast food restaurants 
within a close proximity to schools of varying socioeconomic 
neighborhoods.  They also reported that 38% of schools in lower 
income neighborhoods (income range of $0-32,832) had at least 
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one fast food restaurant within 400 meters as opposed to higher 
income neighborhoods (income range of $58,319+) in which 
only 12% of the schools had at least one fast food restaurant 
within 400 meters.  Furthermore, 77% of schools in the lower 
socioeconomic neighborhood had one or more fast food 
restaurants within 800 meters of the school instead of 47% of 
schools in the higher income neighborhood [191].  It can be 
supposed that a greater exposure to fast food would result in an 
increased consumption. 
 
Our study found a relationship between income and BMI, weight, 
waist circumference, HDL cholesterol, fasting glucose, insulin, 
and HOMA.  In contrast to previous work, our results did not 
indicate a relationship between household income and 
cardiometabolic disease risk factors such as serum lipids, hsCRP, 
blood pressure, or percent body fat.  One reason that the 
present study may not have resulted in the same conclusions as 
previous studies is that in this study income was not corrected 
based on the number of people who lived in the household.  
When comparing those in the same income category, households 
with more people have less of a financial advantage than 
households with less people.  Another contributing factor could 
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be the demographics of our study participants.  Based on where 
participants were recruited from, several of our participants 
might be students.  This can affect household size and income.  
They may have reported their income as individual but then 
included roommates as part of the household.  It should also be 
noted that college students often have a different eating 
schedule than others.  They may end up having classes during 
meal times.  This can create an obstacle to meal time, and 
instead of possibly eating a more balanced meal at home, they 
may eat at a restaurant or may skip the meal all together.  
Instead of trying to carry a meal with them, students may also 
resort to eating something smaller and more convenient that 
may not be as healthy as a meal. 
 
The association between income and CVD risk (increased weight, 
BMI, waist circumference, fasting glucose, insulin, and HOMA; 
decreased HDL cholesterol concentration) within the present 
study has caused several speculations as potential explanations.  
One possibility could relate to how much disposable income a 
person has to spend on medical treatment or preventive 
measures.  It is also possible that individuals with lower income 
may not own a vehicle and therefore may have limited access to 
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medical care, be limited to shopping at stores with a small 
selection of fresh foods, and may not be able to buy groceries 
very often and search for more of the shelf stable foods rather 
than produce that does not last as long.  Also, lack of groceries 
in the home may force people to buy food on the street at 
vendors or fast food establishments. 
 
Employment, diet and CVD risk in Mexican-American 
adults 
Employment status was not observed to affect CVD risk factors 
in this cohort of Mexican-Americans except for HDL cholesterol 
concentrations, which were 15% greater among participants who 
were employed than among unemployed participants. It can be 
speculated that employed participants had a lower risk for CVD 
than those not employed. 
 
Haertel et al. [192] examined the HDL cholesterol concentrations 
of employed women and homemakers and found that employed 
women had significantly higher HDL cholesterol concentrations 
than homemakers.  Moreover, employed women who became 
homemakers had a decrease in their HDL cholesterol 
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concentrations, but homemakers who became employed showed 
no change in HDL cholesterol [192].   
 
Several studies document that physical activity raises HDL 
cholesterol concentrations.  Martin et al. [193], Wood et al. 
[194], Rotkis et al. [195], and Hagan and Gettman [196] found 
that runners had higher HDL cholesterol concentrations than 
sedentary non-runner participants (14.2% higher; 30% higher 
for women and 49% higher for men; 59% higher; and 9.5% 
higher; respectively).  Enger et al. [197] reports a 21% higher 
concentration of HDL for skiers than the controls.  Hartung et al. 
[198] reported that joggers have 35% higher HDL cholesterol 
concentrations and marathoners have 51% higher 
concentrations of HDL cholesterol than inactive participants.  
Some studies also suggest that active lifestyles, more active 
jobs, and employment may beneficially affect HDL cholesterol 
concentrations.  Lehtonen and Viikari [199] found that 
lumberjacks have 36% higher concentrations of HDL cholesterol 
than electricians.     
 
The aforementioned studies also reported significantly lower 
total cholesterol (4-12%) [193, 194, 198], lower LDL cholesterol 
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(9-22%) [193, 194, 198], and lower triglyceride concentrations 
(20-54%) [193, 194, 198, 199] for participants who had more 
active jobs or lifestyles than those who were more sedentary.  
Hagan and Gettman [196] and Enger et al. [197] also reported 
that more active participants have lower total cholesterol, LDL 
cholesterol, and triglyceride concentrations but their data was 
not significant. 
 
Unlike the studies mentioned above [192-199], our study failed 
to find any relationship with employment and CVD risk factors 
except HDL cholesterol.  Furthermore, this study did not 
evaluate the effect of physical activity on CVD risk factors.   
 
After exploring the relationship between employment and diet it 
was found that unemployed individuals had a greater energy 
intake from saturated fatty acids than employed participants.  An 
interesting study by Rathnayake and Weerahewa [200] 
documented that when women work and their household 
receives the extra income, the caloric intake of all individuals 
within the household increases.  As a person’s caloric intake 
increases their consumption of macronutrients also increases, 
including total fat, saturated fatty acids, and trans fatty acids.  
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In contrast, our study did not show a significant relationship 
between employment and caloric, total fat, or trans fatty acid 
intake.   
 
One causal factor may be the high cost of unsaturated fatty acid 
rich foods such as fish and the low cost of foods containing 
saturated fatty acids such as fast food, marbled red meat, or 
high fat dairy products like whole milk.  Those who are not 
employed may seek the cheaper foods that are more likely to 
have saturated fatty acids.  One study found that a person’s 
neighborhood socioeconomic status was positively associated 
with intake of fruits and vegetables [201].  Interestingly, Morris 
et al. [202] found that unemployed men were more likely to gain 
weight than men who remained continuously employed.   
 
According to the National Health Interview Survey (NHIS), heart 
disease, ischemic heart disease, and hypertension were 
negatively correlated with poverty status and income [9, 135].  
Since employment directly affects income and poverty level, it 
can be hypothesized that employment status is associated with 
CVD risk.  Another factor related to employment that could affect 
CVD risk is the location of employment.  Those working in a 
112 
 
restaurant or convenience store have greater access to 
calorically dense foods that do not offer many nutrients [171].  
However, this information was not gathered in the survey used 
for the present study. 
 
In this study, by categorizing participants who are employed as 
either employed full- or part-time it was easier compare 
participants in the same employment category and gather more 
detailed analyses.  Similar to the study by Haertel et al. [192], 
the present study found that employed individuals have higher 
HDL cholesterol than those who are not employed, which in turn 
could result in lower CVD risk. 
 
Education, diet and CVD risk in Mexican-American adults 
Education attainment has been negatively associated with CVD 
risk [18, 34, 61, 71, 122-124, 126-129, 203].  In this study, 
participants with a lower level of education (completed high 
school or less) had 17% greater weight, 14% greater BMI, and 
10% larger waist circumference than participants who only 
completed some college but did not complete college or greater 
education.  In addition, they had a less favorable metabolic 
profile, characterized by having a 27% lower HDL cholesterol 
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concentration and concurrently 44% higher total/HDL cholesterol 
and 50% higher LDL/HDL cholesterol ratios, in addition to having 
55% and 24% greater concentrations of triglycerides and fasting 
plasma glucose, respectively. 
 
In agreement with our findings, education has been shown to 
have a significant negative association with CVD risk factors [71, 
99, 123, 127-129, 203].  Several other trials have found that 
education level is negatively associated with coronary heart 
disease risk [61, 71, 122, 123].  Multiple studies report that 
persons with lower education are more likely to have a clustering 
of more risk factors for developing CVD when compared with 
those who have higher education [71, 122, 123, 127-130, 135, 
137].   
 
Ribisl et al. [71] reported that 39.6% of Hispanics who 
completed 12 years of education were hypertensive as compared 
to only 18.4% of those who completed 16+ years (p<0.001).  
Ribisl et al. also documented that Hispanics with 16+ years of 
education had lower mean plasma cholesterol concentrations 
than Hispanics who completed 12 years (196.2±39.0 mg/dL vs 
213.7±49.7 mg/dL, p=0.01) [71]. 
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A study by Van Minh et al. [123] reported that individuals with 
no formal education are 4.5 times more likely to die from CVD 
than those with a formal education.  Winkleby et al. [203] found 
that Hispanics who had less than 12 years of education had an 
average BMI greater than those who completed only 12 years, 
and those who completed only 12 years of education had an 
average BMI greater than those who completed more than 12 
years of education.   
 
Yala et al. [99] reported that within the group of participants 
with an education level of some high school or less 69% had the 
metabolic syndrome.  On the other hand, only 27% of 
participants with a postgraduate education had the metabolic 
syndrome.  As aforementioned, since the metabolic syndrome is 
the clustering of three or more risk factors that are also risk 
factors for CVD, it is possible that in the study by Yala et al. the 
participants with the lowest education level, who also had the 
highest prevalence of the metabolic syndrome, were the most at 
risk for developing CVD. 
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Kavanagh et al. [127] reported that participants who completed 
high school had a lower waist circumference measurement than 
those who completed some or no high school (96.2 cm vs. 98.9 
cm & 98.8 cm, respectively).  A study by Millar et al. [128] 
shows that 6% of men and 5% of women ages 20-69 who had a 
university/college level education were obese while 13% of men 
and 16% of women in the same age groups but who only had an 
elementary level education were obese.  Millar et al. also 
reported a negative association between education level and 
diastolic blood pressure and cholesterol concentrations [128].  
Those with an elementary level education had a prevalence of 
23% for elevated diastolic blood pressure while those with a 
secondary or university/college level education both had a 
prevalence of 21% for elevated diastolic blood pressure.  When 
looking at serum cholesterol, 7.7% of individuals with an 
elementary education had elevated concentrations of serum 
cholesterol, in contrast to only 4.4% of those with a secondary 
education.  No data was available for prevalence of elevated 
serum cholesterol for those with a university/college education.  
Similarly, Muennig et al. [129] documented that participants 
with less than a high school education have a lower HDL 
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cholesterol concentration than those who completed high school 
or more (50.5 mg/dL vs. 52.4 mg/dL).   
 
In regard to diet, participants of the present study with some 
college education consumed more energy from polyunsaturated 
fatty acids relative to those who completed high school.  
Lasheras et al. [204] explored the relationship between 
education and diet.  They categorized education as low (primary 
education or less) and high (partial secondary education to 
completed university education).  Those with a low education 
consumed a lower percentage of energy from fat, a higher 
percentage of energy from carbohydrates, and a lower 
percentage of energy from protein than those with a high 
education level (39.2% vs. 41.2%, p<0.001; 49.1% vs. 46.8%, 
p<0.05; 13.6% vs. 14.2%, p<0.05, respectively).  Low 
education level participants also consumed a lower percentage of 
energy from monounsaturated fatty acids than high education 
participants (12.5% vs. 13.6%, p<0.01) [204]. 
 
Other studies have also found a positive correlation between 
education and motivation to change behavior related to health in 
order to reduce CVD risk [71, 138].  Education was positively 
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associated with use of health-related print media [71] or 
attending community-based programs intended to help people 
improve their lifestyle [138]. 
 
The present study supports studies previously performed in that 
education has a negative association with CVD risk.  Our study, 
as well as others previously mentioned, sustains the hypothesis 
that education is negatively associated with weight, BMI, and 
waist circumference, and positively associated with HDL 
cholesterol.  However, this study was unable to provide 
significant evidence that education affects macronutrient 
consumption other than the significant relationship with 
polyunsaturated fatty acids. 
 
One speculation as to why education may affect CVD could be 
that a required class before graduating high school in the United 
States is health education.  Those who do not complete high 
school or who do not complete high school in the United States 
may not have taken this class that explains the basic guidelines 
for healthy eating.  Another reason may be that those who are 
less educated might not understand more complex details or 
wording that explains health conditions and preventive 
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measures.  If healthcare providers do not talk to patients at their 
level of understanding, the patient may be confused and may 
not know how to treat, control, or prevent the simplest of health 
conditions [109].  Moreover, those with less education may not 
qualify for higher paying jobs.  Depending on the person’s 
financial responsibilities, a lower paying job may not give that 
person the financial freedom to seek medical help or receive 
preventive treatment.  In relation to diet, those who do not 
understand or know how to read the nutrition food label may not 
be able to make healthy choices or may not know that what they 
currently eat is not as healthy as other options. 
 
Acculturation, diet and CVD risk in Mexican-American 
adults 
In contrast to prior findings [22, 23, 156, 173, 174, 176], this 
study found no significant differences in cardiometabolic disease 
risk factors when stratifying participants based on their 
acculturation level.  However, there is an upward trend for both 
systolic and diastolic blood pressure showing that those whose 
lifestyles reflect more of the traditions and customs of 
Anglos/Americans have higher systolic and diastolic blood 
pressure values than those whose lifestyles reflect the Mexican 
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traditions and customs, although this data is not significant.  
Likewise, HDL has an upward trend from those who practice the 
Mexican culture to those who practice more of the 
Anglo/American culture, but this data is not significant. 
 
Other studies have found that acculturation and length of 
residence in the U.S. are associated with increased risk for CVD 
and metabolic abnormalities [22, 205].  Gordon-Larsen et al. 
[206] reported that longer U.S. residency was associated with 
increased overweight among participants.  They also found that 
the prevalence of being overweight was higher for those 
Hispanics born in the U.S. versus foreign-born immigrants [206].  
Sandquist and Winkleby [207] documented that the country of 
birth (United States or Mexico) and acculturation status were 
associated with waist circumference and abdominal obesity.  
Those born in Mexico had smaller waist circumferences when 
compared to U.S.-born Mexican-Americans [207]. 
 
This study found no significant differences in macronutrient 
consumption when stratifying participants based on acculturation 
category despite the fact that other studies have reported that 
greater acculturation negatively affects diet [23, 156].  Winham 
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and Florian [156] report that participants characterized as 
Hispanic dominant ate more servings of green salad per week 
than their Bicultural/English dominant counterparts (4.2±4.0 
servings vs. 2.7±2.8 servings, p=0.042).  They also found that 
compared to the Bicultural/English dominant participants, 
Hispanic dominant participants ate less servings of hamburgers, 
French fries, and pizza per week (0.7±0.7 servings vs. 1.2±1.0 
servings hamburgers, p=0.023; 0.9±1.0 servings vs. 1.4±1.3 
servings French fries, p=0.001; 0.5±0.8 servings vs. 0.8±0.8 
servings pizza, p=0.043) [156]. 
 
The present study was unable to support previous studies that 
reported the positive relationship between acculturation and CVD 
risk.  One reason for not finding any significant differences in 
cardiometabolic disease risk factors in this study could be 
directly related to the study population.  The majority of our 
participants were educated, employed, and more acculturated to 
the Anglo culture than the minority of the study participants.  
Some of our participants were students studying some aspect of 
health.   
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Diet and CVD risk in Mexican-American adults 
The percent of energy consumed from total fat and 
monounsaturated fatty acids had a positive effect on weight, 
BMI, waist circumference, and insulin.  This signifies that a 
person who consumes a large amount of their energy from fat 
sources is more likely to have a higher weight, BMI, waist 
circumference, and insulin level than a person who consumes a 
smaller amount of energy from fat sources.  The different types 
of fatty acids may also affect anthropometrics and biological risk 
factors.  Weight and waist circumference also had a positive 
association with percent of energy consumed from 
polyunsaturated fatty acids.  Furthermore, percent energy from 
trans fatty acids had a positive association with waist 
circumference, insulin, and HOMA.  This suggests that the type 
of fatty acid has an effect on a person’s CVD risk. 
 
On the other hand, weight and waist circumference had a 
negative association with percent energy from carbohydrates.  
This supports the national dietary guidelines that a diet lower in 
fat and higher in fruits, vegetables, low fat dairy foods, and 
whole grains, all of which are low in fat and contain some 
carbohydrates, helps to reduce risk for certain diseases such as 
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CVD [153-155].  Azadbakht et al. [154] reports that diets 
consisting of a variety of fruits, vegetables, whole grains, and 
low-fat dairy foods have been shown to raise HDL cholesterol, 
lower triglycerides, lower systolic and diastolic blood pressure, 
lower weight, and lower blood glucose concentrations. 
 
One explanation for the fat content (total fat, monounsaturated 
fatty acids, polyunsaturated fatty acids, and trans fatty acids) of 
the diet of the study participants in this study could be the 
culture and traditional foods that Mexicans and Mexican-
Americans consume.  One study found that over the past two 
decades, Mexican-American consumption of legumes, tortillas, 
corn bread, tomatoes, and hot red chili peppers has significantly 
increased [208, 209].  On the other hand, there has been a 
significant decrease in the consumption of melons, fruits other 
than melon, carrots, spinach, greens, collards, kale, and broccoli 
[208, 209].  Since diet has an effect on CVD, this change in diet 
seen over the last two decades could be a contributing factor to 
the increased risk for CVD seen among Mexican-Americans.  
Another factor affecting the change in diet is the country where 
a Mexican-American is born.  Those born in the United States 
have a diet lower in foods considered healthy (high fiber, fruits, 
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vegetables, etc.) and a higher intake of foods containing large 
amounts of fat than those born in Mexico [210]. 
 
In conclusion, the results of our study support previous research 
that income, education, and employment are negatively 
associated with some cardiometabolic risk factors.  Our study 
cannot support studies claiming that acculturation is positively 
associated with cardiometabolic risk factors since we did not find 
any relationship between acculturation and cardiometabolic risk 
factors or diet.     
 
A limitation to this study is that we did not ask people about 
their current insurance status or how often they visit the doctor 
for check-ups.  People who visit the doctor may be able to better 
prevent or receive treatment for diseases such as CVD.  We also 
did not ask about current medications or estimations on monthly 
medical expenses. 
 
Another limitation to the study can be related to the sample size.  
Our study had only 75 participants which may have been too 
small to find a strong relationship between socioeconomic factors 
or acculturation and CVD risk.  Furthermore, our research sites 
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were located in East Phoenix which deterred some people who 
live in West Phoenix from participating due to the distance to the 
sites. 
 
In this study, body fat percentage was not found to be 
significant in any stratification or correlation of data.  One 
possible reason for this is that the equipment used (Tanita 
Corporation, Tokyo, Japan) measured body fat percentage using 
bio-electrical impedance [211], a method that can result in 
different measurements based on the participant’s hydration 
status and location of fat stores. 
 
One aspect of this study was to collect a food frequency 
questionnaire.  This questionnaire was sent to the participant’s 
home where they were asked to fill it out and bring it when they 
came for their appointment.  The questionnaire may have been 
confusing for some of the participants causing them to guess or 
leave a question blank.  The questionnaire asked participants 
about the portion size and how frequently they ate particular 
foods.  Participants may not have known the portion size or 
inaccurately reported how frequently they eat a food.  Therefore, 
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the self reported diet via the food frequency questionnaire may 
not correctly reflect the participants’ diets. 
 
Self reported data may also affect other parts of the survey as 
well.  Incorrect data reporting may affect the data analysis and 
create false positive or negative associations.  For example, if a 
participant was unsure of their household monthly income and 
guessed, the actual monthly income may be in a different 
income group than what the participant reported. 
 
More research on the Mexican-American population living in the 
Phoenix metropolitan area is needed.  Perhaps future studies can 
include a larger sample including people from all areas of 
Phoenix.  Depending on the hypothesis and aims of future 
researchers, it may be beneficial to tailor the survey to include 
or exclude certain data.  For example, data that might help 
determine socioeconomic status would be to gather information 
on monthly bills (rent, utilities, groceries, etc.) or ask for their 
zip code to determine area of residency.  It also might be 
beneficial to include a section to determine literacy, especially 
health literacy. 
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Participants needed for Mexican and Mexican-
American health study 
We want to understand how diet and lifestyle affect health in Mexicans 
and Mexican-Americans 
You could qualify if you:  
• Are of Mexican descent 
• Are 21-60 years old 
• Live in Maricopa county 
• Do not have diabetes or heart disease 
Please contact Kristin Hunt at kristin.j.hunt@asu.edu or call 480-727-1731. 
You will receive a $20 gift card in compensation for your time. 
________________________________________________________ 
Buscamos participantes para un estudio de la 
salud de Mexicanos y Mexicano Americanos 
Queremos entender cómo la dieta y el estilo de vida afectan la salud de los 
mexicanos y mexicanos americanos 
Usted puede calificar si:  
• Es de ascendencia mexicana 
• Tiene 21-60 años 
• Vive en el distrito de Maricopa 
• No tiene diabetes o enfermedades del corazón 
Comuníquese con Kristin Hunt  kristin.j.hunt@asu.edu o llame al 480-727-1731. 
Recibirá una tarjeta de $20 por su tiempo. 
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156 
 
Screening ID#: _______ Date of Phone Call: __________ Recruiter: _________ 
 
Recruiter: Obtain verbal consent to ask eligibility criteria questions by 
reading and asking the following: 
In order to determine whether you qualify or not for the study I need to ask a few 
questions about you and some general health information. This will take about 15 
minutes. Can I ask these questions at this time? 
Para saber si Usted califica para participar en este estudio tengo que hacerle 
algunas preguntas acerca de usted y de su estado general de salud. Esto 
tomará alrededor de 15 minutos. ¿Puedo hacerle estas preguntas en este 
momento? 
        YES  NO  
If YES, continue asking eligibility verification questions. 
If NO, inform participant that you cannot proceed and thank him/her for their 
time. (STOP) 
 
(Do not read) Participant’s gender:   MALE  FEMALE  
ELIGIBILITY VERIFICATION / VERIFICACION DE CTITERIOS DE 
ELEGIBILIDAD  
How old are you? / ¿Cuántos años tiene?  _______________________ 
 (Do not read) Is age between 21 and 60 years?  YES  NO  
Do you consider yourself as Hispano(a)/Latino(a)?  YES  NO  
¿Usted se considera a si mismo(a) como Hispano (a)/Latino(a)? 
 
Do you live in the Phoenix area? / ¿Vive en el área de Phoenix?   
        YES  NO  
How long have you lived in the Phoenix area? _______________________ 
¿Durante cuánto tiempo ha vivido en el área de Phoenix? 
 (Do not read) Is time residing in Phoenix greater than 12 months?  
        YES  NO  
What is your body weight? / ¿Cuánto pesa?  _____________________ 
(Do not read) Is weight at least 110 pounds (50 kg)? YES  NO  
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Are you able to walk without assistance? / ¿Puede caminar sin ayuda?  
        YES  NO  
 
If the answer to any of these questions is NO, read:   (STOP) 
At this point you do not qualify for this study.  Thank you very much for your time. 
En este momento usted no califica para este estudio. Muchas gracias por su 
tiempo. 
If the answer to all of these questions is YES, continue. 
Are you afraid of needles or blood drawing?   YES  NO  
¿Le dan miedo las agujas o que le saquen sangre? 
Do you faint when you have your blood drawn?  YES  NO  
¿Se desmaya cuando le sacan sangre? 
Is it usually hard for medical personnel to draw your blood? 
¿Regularmente le cuesta trabajo al personal médico sacarle sangre? 
YES  NO  
If participant is a woman <50 y old please ask:  
Are you… /¿Está… Pregnant? / Embarazada ?  YES  NO  
   Breastfeeding? / Lactando?  YES  NO  
 
Are you following any of the following diets? / ¿Esta llevando alguna de las 
siguientes dietas? 
 Vegan / vegetariano(a) estricto(a)   YES  NO  
 Very low carbohydrate / Muy baja en carbohidratos YES  NO  
 Atkins / Atkins      YES  NO  
 
 Are you following any other specific diet? What type? ___________ 
 ¿Esta siguiendo alguna otra dieta específica? ¿De qué tipo? 
 (Do not read) Is this a restrictive diet?   YES  NO  
Recruiter: consider any extreme diet or any diet that restricts a major food 
group, except for regular vegetarian diets, as a restrictive diet.  
 
Are you enrolled in any other research study anywhere?  YES  NO  
¿Está participando en cualquier otro estudio de investigación?  
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Has a doctor or health care provider ever told you that you have… 
¿Alguna vez le ha dicho su doctor o personal médico que usted tiene…. 
 Heart disease? / Enfermedad del corazón?  YES  NO  
 Diabetes?      YES  NO  
 Kidney disease? / Enfermedad de los riñones? YES  NO  
 Liver disease? / Enfermedad del hígado?  YES  NO  
 Cancer ?        YES  NO  
 Hepatitis?      YES  NO  
 
Are you taking any cholesterol-lowering medications? YES  NO  
¿Toma medicina para bajar el colesterol? 
   
If the answer to any of these questions is YES, read:   (STOP) 
At this point you do not qualify for this study.  Thank you very much for your time. 
En este momento usted no califica para este estudio. Muchas gracias por su 
tiempo. 
 
 
Is patient eligible for participation? YES  NO  (STOP) 
 
 
As part of this research study we will ask you to one of our ASU study sites for a 
visit in which we will measure your height, weight, waist and hip circumferences, 
and blood pressure, we will draw your blood, and we will ask you to complete a 
survey and a diet questionnaire. You will have to fast for 12 hours before your 
study visit. Are you willing to participate in this study? 
Como parte de este estudio de investigación le vamos a pedir que venga a uno 
de nuestros sitios de investigación en ASU en donde le vamos a medir su 
estatura, peso, circunferencia de cintura y cadera y presión sanguínea, le vamos 
a sacar una muestra de sangre, y le vamos a pedir que complete una encuesta y 
un cuestionario de la dieta. Va a tener que ayunar por 12 horas antes de la 
visita.  ¿Está dispuesto(a) a participar en este estudio? 
        YES  NO, STOP 
 
Have you donated blood in the past 4 weeks?  YES  NO  
¿Ha donado sangre en las últimas 4 semanas? 
If YES, when? / ¿cuándo?   ____________________________ 
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Recruiter: Schedule study visit at least 4 weeks after the blood donation date. 
 
Study visit date and time: _________________ Study ID: ___________ 
 
 
When you come to your study visit we will ask you to sign a consent form before 
we conduct any study-related activities.  Would you like to receive a copy of this 
form in the mail prior to your visit for you to review it? 
Cuando venga a la visita del estudio le vamos a pedir que firme una forma de 
consentimiento antes de realizar cualquiera de las actividades relacionadas con 
el estudio. ¿Le gustaría recibir una copia de esta forma por correo antes de su 
visita para que la revise? 
        YES  NO  
 
You have the option to complete the diet questionnaire in your home prior to your 
study visit and bring it with you at the time of your appointment.  This will shorten 
your study visit by about 45 minutes.  Would you like to fill out the diet 
questionnaire ahead of time? 
Tiene la opción de completar el cuestionario de la dieta en su casa antes de la 
visita del estudio, y traerla el día de su cita.  Esto acortará su visita alrededor de 
45 minutos.  ¿Quiere llenar el cuestionario por adelantado? 
        YES  NO  
Are you allergic to LATEX? / ¿Es alérgico(a) al LÁTEX?  YES  NO  
 
Thank you for your time. / Gracias por su tiempo. 
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SOUTHWEST FOOD FREQUENCY QUESTIONNAIRE 
161 
 
 
162 
 
 
163 
 
 
164 
 
 
165 
 
 
166 
 
 
167 
 
 
168 
 
 
169 
 
 
170 
 
 
171 
 
 
172 
 
 
173 
 
 
174 
 
 
175 
 
 
176 
 
 
177 
 
 
178 
 
 
179 
 
 
180 
 
181 
 
APPENDIX V 
INFORMED CONSENT FORM 
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APPENDIX VI 
MAIN SURVEY 
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INTERVIEW INFORMATION 
INFORMACION DE LA ENTREVISTA 
 
Study ID ___________________________________    Date ________________ 
 
1) Interviewer name / Nombre de Entrevistador: __________________________     
 
2) Language of the interview / Idioma en el que se lleva a cabo la entrevista 
  
1 English / Inglés 
2 Spanish / Español 
3 Both 
 
SOCIODEMOGRAPHIC CHARACTERISTICS/ PERSONAL INFORMATION 
CARACTERISTICAS SOCIODEMOGRAFICAS/ INFORMACION PERSONAL 
 
3) Gender/ Sexo:  1 Male / Hombre  2Female / Mujer  
 
4) How old are you?/ Edad _________    
 
5) Do you identify yourself as any of the following? / ¿Cómo se identifica usted a sí 
mismo? 
 (Interviewer, please read the options) 
 
1 Mexican / Mexicano 
2 American / Americano 
3 Mexican-American / Mexicano-Americano 
4 Hispanic or Latino/ Hispano o Latino 
77 Other (please specify)/ Otro, por favor especifique:_________________ 
99 Refuse / Rehúsa 
 
6) Do you speak?... / Usted habla…  
(Interviewer, please read options) 
 
1 English only / Inglés sólamente 
2 English and Spanish / Inglés y español 
3 Spanish only / Español sólamente 
77 Other (please specify)/ Otro, por favor especifique: _________________ 
99 Refused / Rehúsa 
 
7) What language do you speak in your home most of the time? 
 ¿Que idioma habla en su casa la mayoría del tiempo? 
 
1 English only / Inglés sólamente 
2 English and Spanish / Inglés y español 
3 Spanish only / Español sólamente 
77 Other (please specify)/ Otro, por favor especifique:_________________ 
99 Refused / Rehúsa 
 
12) Are you currently working? / ¿Está trabajando actualmente? 
 
1 Yes / Sí  2 No, go to question # 14 
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13) Which of the following best describes your current employment status? 
¿Cuál de los siguientes describe mejor su estado actual de empleo? 
 
1 Working full-time, 35 hours per week or more / Trabaja de tiempo completo, 35 
horas o más por semana 
2 Working part-time, less than 35 hours per week / Trabaja de medio tiempo, 
menos de 35 horas por semana 
 
Skip to question 15 
 
14) Which of the following best describes your current employment status? 
¿Cuál de los siguientes describe mejor su estado actual de empleo? 
 
(Interviewer please read all options and check only one box.) 
 
3 Unemployed or laid off and looking for work 
Desempleado o suspendido temporalmente por falta de trabajo y buscando 
trabajo 
4 Unemployed and not looking for work / Desempleado y no esta buscando trabajo  
5 Homemaker / Ama(o) de Casa   
6 In school / En la escuela 
7 Retired / Retirado  
8 Disabled, not able to work / Incapacitado, no puede trabajar 
9 Other?  (Please specify) /¿Algún otro?  (Por favor especifique):________ 
 
15) Including money from all salaries/work, government assistance and (if applicable) 
unemployment, what is the total amount of money your household receives PER 
MONTH?   
¿Cuánto es el ingreso total de dinero que su  CASA  recibe  POR MES, incluyendo el 
dinero de todos los salarios de  trabajo, asistencia del gobierno y el desempleo (si 
aplica)? 
 
(Interviewer, if participant is not sure read all the options; make sure answer 
includes food stamps, alimony, and foster care)  
 
1 $0-1000  
2 $1001-2000 
3 $2001-3000 
4 $3001-4000 
5 >$4000 
77 Other amount, (specify) / Otra cantidad, (especifique) ____________ 
88 DK / No sabe 
99 Refused / Rehúsa 
 
16) Last grade you completed in school / Grado final que se ha cumplido en la escuela: 
 
1 Less than 6th grade / Menos de 6º grado 
2 Completed elementary school (6th grade) / Escuela primaria completa (6º grado)  
3 Completed middle school (9th grade) / Escuela secundaria completa (9º grado) 
4 Completed high school (12th grade) / Escuela preparatoria completa (12º grado) 
5 Some college / Algo de universidad 
6 College graduate or higher / Graduado de la universidad o posgrado 
77 Other, (specify) / Otra, (especifique) ____________ 
88 DK / No sabe 
99 Refused / Rehúsa 
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MIGRATION PATTERNS AND ACCULTURATION 
PATRONES DE IMIGRACION Y ACULTURACION 
 
 
25) Where were you born? City: ________________ Country: ___________      99 
Refused 
 ¿En dónde nació? (Ciudad, estado, país) 
 
26) For how long have you been living in the United States? ____months _____years 
 ¿Cuánto tiempo lleva viviendo en los Estados Unidos? 
 
27) Which of the following best describes you? 
     ¿Cuál de los siguientes lo describe mejor? 
(Mark only one answer) 
 
1 1st generation = You were born in Mexico or other country outside the U.S. 
1ª generación = Nació en México u otro país fuera de los Estados Unidos. 
2 2nd generation = You were born in USA; either parents born in Mexico or other 
country.  
2ª generación = Nació en los Estados Unidos; uno de sus padres nació en 
México u otro país. 
3 3rd generation = You were born in USA, both parents born in USA and all 
grandparents born in Mexico or other country. 
3ª generación = Nació en los Estados Unidos; sus dos padres nacieron en los 
Estados Unidos y todos sus abuelos nacieron en México u otro país. 
4 4th generation = You and your parents born in USA; at least one of your 
grandparents born in Mexico or other country with reminder born in the USA. 
4ª generación = Usted y sus padres nacieron en los Estados Unidos; por lo 
menos uno de sus abuelos nació en México u otro país.  Sus otros abuelos 
nacieron en los Estados Unidos. 
5 5th generation = You and your parents born in the USA and all grandparents 
born in the USA 
5ª generación = Usted y sus padres nacieron en los Estados Unidos y todos sus 
abuelos nacieron en los Estados Unidos. 
 88 DK / No sabe 
 99 Refused / Rehúsa 
 
 
The following questions are about how much you identify with the Hispanic culture and 
the American culture.  Please indicate how often you do each of the following. 
Las siguientes preguntas son acerca de cuánto se identifica con la cultura hispana y la 
cultura americana. Por favor indique con qué frecuencia hace cada una de las 
siguientes.  
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 Not at 
all 
Nunca 
Very little or 
not very often 
Casi nunca o 
pocas veces 
Moderately 
Moderadamente 
Much or very 
often 
Muchas veces o 
frecuentemente 
Extremely often or 
almost always 
Muchas veces o 
casi siempre 
28) I speak Spanish 
Hablo español 1 2 3 4 5 
29) I speak English 
Hablo inglés 1 2 3 4 5 
30) I enjoy speaking Spanish 
Me gusta hablar en español 1 2 3 4 5 
31) I associate with Anglos 
Me asocio con anglos 1 2 3 4 5 
32) I associate with Mexicans 
and/or Mexican Americans 
Me asocio con Mexicanos o 
con Mexicano Americanos 
1 2 3 4 5 
33) I enjoy listening to 
Spanish language music 
Me gusta la música Mexicana 
(música en idioma español) 
1 2 3 4 5 
34) I enjoy listening to 
English language music 
Me gusta la música en idioma 
inglés 
1 2 3 4 5 
35) I enjoy Spanish language 
TV 
Me gusta ver programas en 
la televisión que sean en 
español 
1 2 3 4 5 
36) I enjoy English language 
TV 
Me gusta ver programas en 
la televisión que sean en 
inglés 
1 2 3 4 5 
37) I enjoy English language 
movies 
Me gusta ver películas en 
inglés 
1 2 3 4 5 
38) I enjoy Spanish language 
movies 
Me gusta ver películas en 
español 
1 2 3 4 5 
39) I enjoy reading (e.g. 
books) in Spanish 
Me gusta leer (libros) en 
español 
1 2 3 4 5 
40) I enjoy reading (e.g. 
books) in English 
Me gusta leer (libros) en 
inglés 
1 2 3 4 5 
41) I write (e.g. letters) in 
Spanish 
Escribo (cartas) en español 
1 2 3 4 5 
42) I write (e.g. letters) in 
English 
Escribo (cartas) en inglés 
1 2 3 4 5 
43) My thinking is done in the 
English language 
Mis pensamientos ocurren en 
el idioma inglés 
1 2 3 4 5 
44) My thinking is done in the 
Spanish language 
Mis pensamientos ocurren en 
el idioma español 
1 2 3 4 5 
45) My contact with Mexico 
has been 
Mi contacto con México ha 
sido 
1 2 3 4 5 
46) My contact with USA has 
been 
Mi contacto con los Estados 
Unidos ha sido 
1 2 3 4 5 
47) My father 
identifies/identified himself as 
‘Mexicano’ 
Mi padre se identifica (o se 
identificaba) como Mexicano 
1 2 3 4 5 
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 Not at 
all 
Nunca 
Very little or 
not very often 
Casi nunca o 
pocas veces 
Moderately 
Moderadamente 
Much or very 
often 
Muchas veces o 
frecuentemente 
Extremely often or 
almost always 
Muchas veces o 
casi siempre 
48) My mother 
identifies/identified herself as 
‘Mexicana’ 
Mi madre se identifica (o se 
identificaba) como Mexicana 
1 2 3 4 5 
49) My friends, while I was 
growing up, were of Mexican 
origin 
Mis amigos(as) de mi niñez 
eran de origen mexicano 
1 2 3 4 5 
50) My friends, while I was 
growing up, were of Anglo 
origin 
Mis amigos(as) de mi niñez 
eran de origen Anglo 
Americano 
1 2 3 4 5 
51) My family cooks Mexican 
foods 
Mi familia cocina comida 
mexicana 
1 2 3 4 5 
52) My friends now are of 
Anglo origin 
Mis amigos recientes son 
Anglo Americanos 
1 2 3 4 5 
53) My friends now are of 
Mexican origin 
Mis amigos recientes son 
Mexicanos 
1 2 3 4 5 
54) I like to identify myself as 
an Anglo American 
Me gusta identificarme como 
Anglo Americano(a) 
1 2 3 4 5 
55) I like to identify myself as 
Mexican American 
Me gusta identificarme como 
Mexicano(a) Americano(a) 
(Estadounidense de origen 
mexicano) 
1 2 3 4 5 
56) I like to identify myself as 
Mexican 
Me gusta identificarme como 
Mexicano(a) 
1 2 3 4 5 
57) I like to identify myself as 
an American 
Me gusta identificarme como 
Americano(a) 
1 2 3 4 5 
 
 
 
END OF INTERVIEW 
 
Interviewer: Read… 
Thank you so much for your time. / Muchas gracias por su tiempo 
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APPENDIX VII 
ANTHROPOMETRICS DOCUMENTATION FORM 
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Anthropometrics Documentation Form 
 
Study ID  _______________________________    Date ___________________ 
 
 
 
 
 Measurement 
1 
Measurement 
2 
Measurement 
3 
 
   
HEIGHT 
   
(cm) ———— ———— ———— 
 
   
WEIGHT 
   
(kg) ———— ———— ———— 
 
   
WAIST 
CIRCUMFERENCE 
   
(cm) ———— ———— ———— 
 
   
HIP 
CIRCUMFERENCE 
   
(cm) ———— ———— ———— 
 
   
BLOOD 
PRESSURE 
   
(mm Hg) ———— ———— ———— 
 
   
BODY MASS 
INDEX (BMI)  
- Calculated   
(kg/m2) 
  ———— 
 
 
 
Initials of person taking measurements __________ 
 
If procedures were NOT completed, indicate rescheduling date and time: ______ 
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BLOOD SAMPLE DOCUMENTATION FORM 
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Blood Draw Documentation Form 
 
Study ID: _______________ Date: _________________Time: ______________ 
 
Phlebotomist: ____________________________________________________ 
 
Before you draw the blood, please ask the patient the following questions to 
assess how well the participant complied with the guidelines to prepare him/her 
for the blood draw.  If the participant did not comply with the guidelines, 
reschedule the blood draw.  Remind them of each of the guidelines and 
encourage him/her to follow the guidelines. 
 
1.  At what time did you last eat or drink something (excluding water)? ________ 
 ¿A qué hora consumió el último alimento o bebida (excepto agua)? 
 
If he/she ate or drank something less than 8 hours ago, reschedule the 
blood draw. 
 
 
2.  Have you had coffee in the past 12 hours?    Yes   No 
 ¿Tomó café en las últimas 12 horas? 
 
3.  Have you exercised in the past 12 hours?   Yes   No 
 ¿Hizo ejercicio en las últimas 12 horas? 
 
 
Please confirm that the following tubes of blood were collected: 
 
 One 2 ml gray top 
 One 6 ml lavender top 
 One 10 ml lavender top 
 Two 10 ml red top 
 
Blood draw successfully completed?     Yes   No 
 
 
Comments: 
________________________________________________________________ 
 
________________________________________________________________  
 
________________________________________________________________  
 
 
If blood was NOT collected, indicate rescheduling date and time: ____________ 
 
 
Proceed to Survey Completion.  
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ACCULTURATION RATING SCALE 
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The following is the Acculturation scoring instructions as 
explained by Cuellar et al. [182]. 
ARSMA-II employs a bilingual format with both language 
versions (English and Spanish) on the same page.  Scale I of 
ARSMA-II is a 30-item self-rating scale composed of an Anglo 
Orientation Subscale (AOS) of 13 items (Items 2, 4, 7, 9, 10, 13, 
15, 16, 19, 23, 25, 27, and 30) and a Mexican Orientation 
Subscale (MOS) composed of 17 items (Items 1, 3, 5, 6, 8, 11, 
12, 14, 17, 18, 20, 21, 22, 24, 26, 28, and 29).  The sum of the 
AOS scale is divided by 13 to obtain a mean score for that 
subscale.  The sum of the MOS is divided by 17 to obtain a mean 
for that subscale.  The MOS mean is subtracted from the AOS 
mean to obtain a linear acculturation score that represents an 
individual’s score along a continuum from very Mexican oriented 
to very Anglo oriented.  The acculturation score can be used to 
obtain an acculturation level for the subject by employing the 
suggested cutting scores shown in Table 1 below.  These cutting 
scores were selected based on standard deviation unites from 
the mean of the combined sample of 379 subjects representing 
five generations. 
Individuals scoring greater than -1/2 standard deviation 
below the mean on both the AOS and the MOS scales are 
classified as high integrated biculturals.  Similarly, using 
fractional deviations from the AOS and MOS means, cutting 
scores were set for defining low integrated biculturals as those 
individuals scoring between -1.5 standard deviations below the 
mean to -.5 standard deviations below the mean on both the 
MOS and AOS scales. 
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Table 16. Cutting Scores for Determining Acculturation Level Using 
ARSMA-II 
Acculturation 
Levels Description 
ARSMA-II 
Acculturation Score* 
Level I Very Mexican oriented < -1.33 
Level II Mexican oriented to approximately 
balanced bicultural 
≥ -1.33 and ≤ -.07 
Level III Slightly Anglo oriented bicultural > -.07 and < 1.19 
Level IV Strongly Anglo oriented ≥ 1.19 and < 2.45 
Level V Very assimilated; Anglicized > 2.45 
*Raw score means were used to calculate the Acculturation Score.  The 
choices selected for each item are added and divided by the number of 
items on the MOS and AOS scales separately to obtain the raw score mean 
for each scale.  These means were used in the formula:  
Acculturation Score = AOS (mean) – MOS (mean). 
 
 
